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ABSTRACT 
 
 Nitric oxide synthases (NOS) produce L-citrulline and nitric oxide (NO) in two 
turnovers from L-arginine via the bound intermediate, N-hydroxy-L-arginine. NO is an 
important biological signaling molecule, and NOS-like enzymes have been identified in 
all kingdoms of life. NOS enzymes utilize electrons from a reductase domain as well as a 
unique redox-active cofactor, tetrahydrobiopterin, in the activation of dioxygen. The 
NOS catalytic mechanism is only partially known, with proposed hihg-valent 
oxygenating intermediates similar to those of other monooxygenases. In the continued 
effort to understand the mechanism by which NOS catalytically produces NO, we have 
chosen to study NOS from the thermostable, nonpathogenic bacterium Geobacillus 
stearothermophilus (gsNOS).   
In this work, covalently modified gsNOS with a ruthenium(II) diimine 
photosensitizer has been prepared to circumvent the need for an external reductase 
domain, while maintaining access to the substrate-binding channel. In this way, we hoped 
to produce the NOS ferrous state by rapid electron injection and to be able to access 
intermediates that form downstream. Chapter two describes the engineered gsNOS for 
selective cysteine labeling with [Ru(bpy)2(IA-phen)]2+ (IA-phen = 5-iodoacetamido-1,10-
phenanthroline) to form the conjugate Ru(II)K115C-gsNOS. The labeled protein was 
characterized by mass spectrometry, UV-visible absorbance, and circular dichroism 
spectroscopy. Ru(II)K115C-gsNOS was crystallized and its structure solved to 2.6 Å 
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resolution. Chapter three details phototriggered reduction by laser flash-quench 
methodology using the reversible, reductive quencher p-methoxy-N,N-dimethylanaline. 
Transient absorption studies have shown that rapid phototriggered heme reduction occurs 
on the order of 625 ns. Binding of substrates and/or cofactor is known to alter the heme 
reduction potential in NOS. However, these observed reduction rates are independent of 
substrate/cofactor, suggesting that the system is driving force optimized. Studies 
performed in the presence of oxygen were complicated by side-reactions with the 
ruthenium label and small molecule quencher. Excitingly, enzymatic turnover was 
achieved by steady-state LED illumination at 470 nm using the irreversible reductive 
quencher diethyldithiocarbamate, and is described in chapter four. NO produced from 
light-driven Ru(II)K115C-gsNOS catalysis was measured by the Griess Assay and L-
citrulline production confirmed by liquid chromatography-mass spectrometry. In chapter 
five, we show how phototriggered heme reduction can be used to monitor CO binding 
and potential studies of gas diffusion pathways, and substrate/cofactor effects are 
discussed. In all, the development of this ruthenium-modified gsNOS system has enabled 
preliminary studies of reduction kinetics, diatomic ligand binding, and light-driven 
catalysis and may provide a useful platform for further investigation into the catalytic 
cycle of NOS. 
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INTRODUCTION 
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1.1 Nitric Oxide Synthases 
 The radical nitric oxide (NO) is now recognized as an essential biological 
regulator after having been long considered solely a poison and pollutant.1 NO has many 
roles, such as an endothelial relaxing factor, a protective immunocytotoxin, and a 
signaling molecule in the nervous system.2 NO is produced in mammals by a family of 
nitric oxide synthases (mNOS). The family contains three isoforms: endothelial (eNOS), 
inducible (iNOS), and neuronal NOS (nNOS) and NOS dysfunction is implicated in a 
variety of disease states.3,4 mNOS catalyzes the oxidation of L-arginine (L-Arg) to L-
citrulline (L-Cit) and NO. The reaction proceeds in two turnovers with N!-hydroxy-L-
arginine (NOHA) as a stable, enzyme-bound intermediate5 and the overall reaction is 
shown in Scheme 1.1.  
 
Scheme 1.1 Overall reaction for the NOS-catalyzed production of NO and L-Cit starting 
with L-Arg, via the intermediate NOHA. The oxygen atom in both NO and L-Cit come 
from dioxygen; the nitrogen atom in NO is derived from the guanidinium nitrogen in L-
Arg.  
 
All three mNOS isoforms are active as homodimers that contain an oxygenase 
domain linked to reductase domain.6 The oxygenase domain houses a cysteine-ligated 
heme, as well as substrate and redox cofactor binding sites that create the active site of 
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the enzyme. The dedicated reductase domain is connected through a calmodulin linker 
and has binding sites for flavin adenine dinucleotide (FAD), flavin mononucleotide 
(FMN), and nicotinamide adenine dinucleotide phosphate (NADPH).5 In eNOS and 
nNOS, the reductase domain is regulated by the calmodulin peptide linker that prevents 
electron transfer in the absence of bound Ca2+.7 In all cases, the reductase domain is the 
initial source of electrons necessary to initiate catalysis; the unique redox-active cofactor 
(6R)-5,6,7,8-tetrahydrobiopterin (H4B, pterin) provides additional reducing equivalents to 
complete the cycles. While there is structural data available for the separate reductase and 
oxygenase domains8,9,10 there is no crystal structure for full-length mNOSs to date, and 
thus the in vivo connectivity/domain interaction is only estimated (Figure 1.1). 
 
Figure 1.1 Illustrative representation of possible full-length NOS domain interactions, 
cofactor binding, and electron flow in the production of NO (adapted from Alderton5 and 
Nguyen11). 
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1.2 Bacterial NOS 
 Many bacterial NOS homologs have now been identified that exhibit NOS-like 
activity,12 leading researchers over the last decade to look toward them as useful parallel 
systems for studying mNOS. As NO produced from a certain mNOS is used as a toxin 
against bacterial infection,7 the biological role of NO in prokaryotes remains an open 
question. However, in vivo NO production has now been confirmed13,14  and current 
research suggests that different bacteria may use NO quite differently from mammals.2 
Bacterial NOS shares remarkably similar three-dimensional structure and sequence 
homology with mNOS,15 however there are some notable differences. Bacterial NOS 
lacks the N-terminal motif at the dimer interface involved in zinc coordination and the N-
terminal hook involved in H4B binding.2 The most striking difference is the lack of a 
dedicated linked reductase domain in bacterial NOS (with the exception of Sorangium 
cellulosum).16 Three bacterial forms of NOS have been crystallized from Bacillus subtilis 
(bsNOS),17 Staphylococcus aureus (saNOS),18 and Geobacillus stearothermophilus 
(gsNOS).19 All form stable dimers and bind H4B; the ability to bind cofactor in the 
absence of the hook is explained by dimer interface residue substitutions. Overall, their 
structures are very similar to each other and to the oxygenase domains of mNOS (Figure 
1.2). The winged !-sheet core is maintained around the active site, as is the conserved 
Trp that stacks with the heme on the proximal side and hydrogen bonds with the Cys 
thiolate sulfur. The hydrophobic “helical lariat” involved in pterin cofactor binding 
makes up much of the dimer interface and is surrounded by the T-shaped helices that 
associate across the two subunits.2 
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Figure 1.2 Comparison of representative dimeric structures of bacterial and mammalian 
NOS showing nearly identical overall folds: a) Bacillus subtilis, highlighting alternate 
bound cofactor, tetrahydrofolate (THF); b) inducible NOS from mammalian 
macrophages, highlighting bound cofactor, tetrahydrobiopterin (H4B) and the missing N-
terminal hook in pink (reproduced from Pant17).  
 
Despite slight differences in heme electronics and substrate/cofactor binding, 
bacterial NOS and mNOS are suggested to share the same mechanism for catalytic 
production of NO from L-Arg via the bound NOHA intermediate20 when supplied with 
electrons from exogenous reductase domains. There are various advantages to working 
with bacterial NOS including good overexpression yields in E. coli and increased 
stability,21 particularly in the case of the thermostable gsNOS. Due to their overall 
similarities in structure and reactivity (both in vitro and in vivo),13,19,22,23 it is thought that 
lessons learned from these NOS-like enzymes can be applied to their mammalian 
counterparts. 
 
1.3 Mechanism of Catalytic NO Production   
 NOS belongs to a superfamily of cysteine thiolate-ligated heme enzymes, largely 
consisting of cytochromes P450 and including chloroperoxidase (CPO).24 These 
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monooxygenases activate dioxygen (O2) to incorporate an oxygen atom into a variety of 
substrates.25 P450s, in particular, catalyze a truly impressive array of regio- and 
stereospecific transformations, including hydroxylations of saturated hydrocarbons, 
aromatic oxidations, and epoxidations.26 Owing to its synthetic utility,27 as well as its 
biological importance, the reactivity and mechanism of P450 have been extensively 
investigated.28 The full two-step mechanism of NO production by NOS is not yet fully 
understood.29 The first turnover is a two-electron oxidation of L-Arg resulting in the 
hydroxylation of a guanidinium nitrogen to form NOHA in a reaction that is nearly 
identical to that of P450-catalyzed hydroxylation. Thus, the first turnover is thought to 
follow a cycle similar to that of the well-studied P450s; the second turnover, a one-
electron oxidation, is thought to follow a unique mechanism.30 The NOS resting state is a 
six-coordinate aquo-ferric heme with an equilibrium of low- and high-spin states 
(“mixed-spin”).  Substrate binding (L-Arg in the first cycle and NOHA in the second) in 
the pocket sterically displaces water to form a five-coordinate high-spin ferric state.25 
Ferric NOS is reduced by one electron from the reductase domain to give a ferrous 
species that can bind O2. Oxygen binding gives a ferrous-oxy species (often represented 
as a ferric-superoxide), that is further reduced by one electron supplied by the redox-
active cofactor H4B.31 The next experimentally observed species is the ferric resting state 
with bound NOHA. The missing reactive intermediate is thought to be a ferryl porphyrin 
radical cation,32 analogous to compound I (Cpd I) in P450. The second turnover of the 
NOS catalytic cycle has similar steps: reduction, O2-binding, and a second reduction by 
H4B. From there, the next observed species is the ferric-NO, which then releases NO (and 
L-Cit) to complete the cycle. The reactive intermediate responsible for the oxygenation of 
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NOHA to form L-Cit as product in the second turnover is proposed to be either a 
hydroperoxo ferriheme33 or Cpd I formed by subsequent protonation and water loss.32 
Known and proposed intermediates of both turnovers in the catalytic production of NO 
by NOS are shown in Figure 1.3. Spurred on by the desire to capture these elusive 
intermediates and encouraged as pieces of the puzzle fall into place, the exciting field of 
NOS research continues to grow.  
 
 
Figure 1.3 Putative mechanism for the catalytic production of NO by NOS enzymes: (1) 
first turnover formation of NOHA from L-Arg, shown in blue path; (2) second turnover 
formation of L-Cit and NO radical from NOHA, shown in orange path. The proposed 
oxygenating intermediates are in brackets. 
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1.4 Interaction with Diatomic Molecules  
While great strides have been made to characterize the unique reactivity of NOS 
enzymes, there are still many questions that remain unanswered about NO production by 
NOS. In addition to definitively identifying the reactive intermediates involved in these 
heme-based oxygenations, it is of interest to understand how NOS interacts with diatomic 
ligands: O2 is a reactant (cosubstrate) and NO is a product in this very complex 
transformation. Distinct gas diffusion pathways are possible and the heme interaction 
with diatomics is sensitive to substrate and cofactor binding.20,31,34 A wide variety of 
techniques, including UV-visible spectroscopy,20 stopped-flow spectrophotometry,35 X-
ray crystallography,36,37 electron paramagnetic resonance (EPR), electron-nuclear double 
resonance (ENDOR)32 and Raman spectroscopies38,39 have been used by researchers to 
gain insight into the interactions of diatomics with mNOS and bacterial NOS. Studies 
involving O2 are challenging due to its redox activity, so both NO and carbon monoxide 
(CO) have been used as surrogates for gas binding while single-turnover experiments 
have been used for studies of NO release.16,40–42 
A significant difference between mammalian and bacterial NOSs is in the notably 
slower NO-release rates observed for bacterial NOSs.2 Structure and sequence 
comparisons reveal variations in a few key residues thought to “gate” NO release.17,42 For 
example, a conserved Val located directly above the distal side of the heme in mNOS is 
an Ile in many bacterial NOSs and is thought to slow gas release by sterically 
constraining the active site.43 The second gate residue shows more variation, both in 
position and size of residue, but again NO-release rates seem correlated with steric 
bulk.19,42 These gate effects on NO-release have been studied by single-turnover 
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experiments. Flash photolysis of ferrous-CO adducts is another useful technique for 
studying interactions of heme proteins with diatomics.44–46 Excitation by visible light 
causes rapid CO dissociation and because the iron retains its oxidation state, the released 
CO can rebind. This rebinding process can be followed by transient absorption (TA) 
spectroscopy that monitors changes in the heme Soret maxima (e.g., ferrous NOS-CO 
!max = 446 nm vs. ferric NOS !max = 400 nm).37 Preliminary CO-photolysis experiments 
have been performed to determine whether diatomic ligand rebinding is also affected by 
channel gating.47  
 
1.5 Accessing Intermediates  
The high reactivity and short lifetimes of the proposed oxygenating intermediates 
in the NOS cycle, along with the relatively slow rates of electron injection, has prohibited 
their observation. Furthermore, the dependence on a reductase domain as well as the 
benchtop instability of full-length mNOS has created difficulties for researchers. One 
way to access these types of reactive intermediates is through rapid phototriggered 
electron transfer (ET); indeed, previous work in the Gray group has found success using 
what is now known as “flash-quench” methodology48 (Scheme 1.2). The excited state of 
ruthenium(II)diimine photosensitizers, such as [Ru(bpy)3]2+ (bpy = 2,2’-bipyridine), lies 
~2.1 eV above the ground state with a lifetime greater than 600 ns in water.49 This 
excited state is accessible by illuminating into the metal-to-ligand charge-transfer 
(MLCT) band at 400–500 nm (the “flash”). Introduction of another small molecule of an 
appropriate reduction potential (the “quench”) can lead to the formation of either a potent 
-1.3 V reductant, [Ru(bpy)3]1+, or +1.3 V oxidant, [Ru(bpy)3]3+ allowing injection or 
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removal of an electron from the system of interest.49 The flash-quench system can by 
tuned by photosensitizer (metal and/or ligands) or by quencher choice: reductive vs. 
oxidative and reversible vs. irreversible. The use of reversible quenchers results in the 
eventual return to the resting oxidation states through back-reaction with either the 
photosensitizer or a resultant redox species in solution. Irreversible quenchers undergo 
chemistry upon interaction with the photosensitizer excited state that prevents any further 
back-reaction and are often useful to further extend the lifetime of the desired 
reductant/oxidant.50 The power of the flash-quench system lies in the rapid production of 
an extremely potent reductant or oxidant, depending on choice of quencher, and the 
extended lifetime afforded through charge separation, buying time to perform the desired 
redox chemistry. This technique has been successfully applied to small molecule 
systems51,52 as well as proteins.53 
 
Scheme 1.2 Flash-quench scheme showing both reductive and oxidative quenching 
routes a) Reduction potentials are given for Ru(bpy)3 species in water.49 b) Ru represents 
Ru(bpy)3, Q+ and Q- represent oxidative and reductive small-molecule quenchers, 
respectively.  
 
 Previous work in the Gray group has found success in accessing high-valent 
reaction intermediates in heme systems using flash-quench methodology. Changes in the 
spin and oxidation states of heme systems result in pronounced shifts in absorption 
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features, such as in the Soret and Q bands.25 These shifts can be monitored by transient 
absorption (TA) spectroscopy and provide an optical handle by which to follow a 
reaction. The highly solvent-exposed, c-type heme in microperoxidase- 8 (MP8)54 was an 
ideal initial target for photooxidative studies and led the way to investigations of 
horseradish peroxidase (HRP).50 In both cases, the excited state of [Ru(bpy)3]2+ in 
solution was oxidatively quenched to form [Ru(bpy)3]3+ which was able to oxidize the 
heme, allowing observation of both ferryl porphyrin radical cation (Cpd I) and the ferryl 
(Cpd II) species. The reversible quencher, [Ru(NH3)6]3+, worked well for MP8, but a 
longer [Ru(bpy)3]3+ oxidized state was required to allow for ET with the slightly less 
exposed heme in HRP. In the latter case, use of an irreversible quencher was necessary to 
extend the lifetime of Ru(III) oxidants. Extension to more complex systems, such as 
P450s and iNOSoxy, proved difficult due to the much more buried heme environments of 
these enzymes. In a project subsequently known as “wires,” modified photosensitizers 
were synthesized with an attached tail that mimicked the appropriate substrate for the 
given enzyme.55 As such, the substrate tail gained access to the buried active site, thus 
establishing electronic communication between the heme and the [Ru(bpy)3]2+ sensitizer. 
High-valent intermediates were not observed; however efficient heme photoreduction 
was achieved.56–58 A fundamental issue with these “wires” arises from the fact that in 
order to engage in ET, they must bind in the substrate channel. This prevents catalysis 
and excludes H2O and/or O2 needed to access Cpd I or II. 
 Recent work with P450-BM3 has overcome the problems described above by 
covalently linking a Ru(II)diimine photosensitizer to the surface of the protein, enabling 
through-bond ET without blocking the substrate channel.59 By using site-directed 
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mutagenesis to engineer a single, nonnative surface cysteine, researchers in our group 
were able to control the distance to the active site as well as ensure unique labeling. 
Flash-quench experiments using a reversible oxidative quencher led to observation of 
various porphyrin radical cation intermediates and Fe(IV)-hydroxide (protonated Cpd II) 
by TA spectroscopy. This was the first example of a photochemically generated Cpd II in 
P450. Analysis of their TA data suggested formation of six distinct species following 
laser excitation. Three species were easily identified and the three remaining 
intermediates were determined by extensive modeling, partially constrained by 
previously published results from the oxidation of HRP50 and MP8.54 An illustration of 
the sequential kinetics model used for analysis of P450-BM3 oxidation is shown in 
Figure 1.4. 
 
Figure 1.4 Diagram of the model for photochemical P450-BM3 heme oxidation used in 
transient absorption kinetics analysis (figure reproduced from Ener59).  
 
 
metry; no further increase in the peak at 54.2 kDa (corresponding to the
predicted mass of RuIIK97C-Fe
III
P450) was observed after 2 h. Excess
½RuðbpyÞ2ðIA-phenÞ$2þ was removed during concentration in 30 kDa filters,
followed by desalting on an FPLC HiPrep column. Photosensitizer-labeled
(RuIIK97C-Fe
III
P450) and unlabeled proteins were separated using an anion
exchange MonoQ column. The labeled protein was characterized by CO
binding, and purity was confirmed by SDS-PAGE and mass spectrometry.
The conjugate RuIIK97C-Fe
III
P450 demonstrated activity in the hydroxylation
of lauric acid via the peroxide shunt (21).
Crystal Structure Determination. Crystals of RuIIK97C-Fe
III
P450 were obtained by
the sitting-drop vapor diffusionmethod: 27 mg∕mL RuIIK97C-FeIIIP450 in 10mM
potassium phosphate, pH 8.4, were mixed with a crystallization well solution
of 2 M ðNH4Þ2SO4 (wt∕vol) in a 1∶1 ratio (vol∕vol). Crystals formed over a
period of 2 d at 4 °C, and were flash-frozen directly from the crystallization
solution. X-ray diffraction data were collected at 100 K using beamline 7-1 at
the Stanford Synchrotron Radiation Laboratory. Detailed description of the
structure determination is provided in the SI Text. Statistics for data collection
and refinement are shown in Table S1. Atomic coordinates and structure
factors were deposited in the Protein Data Bank under the entry 3NPL.
Laser Flash-Quench. Samples consisting of ½RuðbpyÞ2ðIA-phenÞ$2þ or RuIIK97C-
FeP450 (∼10 μM) with and without quencher (17 mM ruthenium(III)-hexaam-
mine trichloride) were prepared in buffered solution (pH 6, 20 mM sodium
acetate; pH 7, 20 mM sodium acetate; pH 8, 50 mM sodium borate or 50 mM
Tris). Deoxygenation was achieved via 30 gentle pump-backfill cycles with
argon. Samples were excited with 10 ns laser pulses at 480 nm, delivered
by an optical parametric oscillator pumped by the third harmonic from a
Spectra Physics Q-switched Nd:YAG laser. Luminescence decays were moni-
tored at 630 nm. Single wavelength TA kinetics were monitored every
10 nm from 390–440 nm, averaging ∼500 shots per wavelength. Data from
five separate timescales (2 μs, 40 μs, 400 μs, 10 ms, and 500 ms) were collected
and spliced together to produce full kinetics traces.
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1.6 Moving Forward with gsNOS 
 In the continued effort to understand the mechanism by which NOS catalytically 
produces NO, this thesis details work with NOS from the thermostable, nonpathogenic 
bacterium Geobacillus stearothermophilus (gsNOS). gsNOS was first crystallized and 
structurally characterized in 2006.19 The enhanced stability of this enzyme, as well as 
other unique properties, presents a convenient system to study the NOS catalytic cycle. 
The structure of gsNOS is quite similar to other bacterial NOS-like enzymes, as well as 
mNOSoxy: Cys76 provides thiolate ligation to the heme and stacking with the conserved 
Trp70 is maintained. The H4B cofactor-binding site is formed by interface residues: 
Trp332, Phe347 in subunit one and Trp334, Arg252 in subunit two (Figure 1.5-a). 
However, there are some differences that seem to have pronounced effects on its 
interactions with diatomic molecules. Previous studies demonstrated that the ferrous-oxy 
species is remarkably long-lived in gsNOS,19 with a lifetime on the order of >60 seconds 
at 4 °C, compared to seconds in other NOS systems. gsNOS also has the slowest reported 
NO release rate of both mNOS and bacterial NOS systems; this is ascribed to the bulkier 
“gate” mutations described previously. Structural analysis revealed another substitution 
(Arg365 for Lys356 in bsNOS) that plays a role in creating a more constrained active site 
in gsNOS. This arginine residue is engaged in a hydrogen-bonding network involving 
Asp225 and Ser224 that ultimately pushes the Ile223 gate residue approximately 0.6 Å 
closer to the heme iron atom (Figure 1.5-b). This further tightening could also play a role 
in the slower observed NO release rates. While the dimer interface overlays nearly 
perfectly with bsNOS, the overall fold of gsNOS appears more compact. Additionally, 
Resonance Raman spectroscopy has shown unique heme environments in both the distal 
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and proximal pockets that are very sensitive to substrate binding.39 In experiments with 
CO bound at the heme, L-Arg and NOHA are shown to each stabilize different 
conformations as manifested in the Fe-CO and Fe-Cys stretching modes. 
 
 
 
Figure 1.5 a) structure of gsNOS dimer (subunit interface residues involved in H4B 
binding shown in violet); b) gsNOS active site highlighting key residues (NO-release 
“gate” residues shown in pink, hydrogen-bonding network responsible for constrained 
active site colored by element, conserved Trp, and proximal heme-thiolate by Cys76) 
PDB code 2FLQ, figure made with MacPymol 2009. 
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In this work, we covalently modified gsNOS with a ruthenium(II) diimine 
photosensitizer to circumvent the need for an external reductase domain, while 
maintaining access to the substrate-binding channel. In this way, we hoped to produce the 
NOS ferrous state by rapid electron injection and be able to access intermediates that 
form downstream. Chapter two describes our engineered gsNOS for selective cysteine 
labeling with [Ru(bpy)2(IA-phen)]2+ (IA-phen = 5-iodoacetamido-1,10-phenanthroline) 
to form the conjugate Ru(II)K115C-gsNOS, as well as its structural characterization by X-
ray crystallography. Chapter three details phototriggered reduction by laser flash-quench 
methodology using the reversible, reductive quencher p-methoxy-N,N-dimethylanaline 
(MeODMA). Enzymatic turnover was achieved by steady-state LED illumination and is 
described in chapter four. In chapter five, we show how phototriggered heme reduction 
can be used to monitor CO binding and potential studies of gas diffusion pathways as 
well as substrate/cofactor effects are discussed. In all, the development of this ruthenium-
modified gsNOS system has enabled preliminary studies of reduction kinetics, diatomic 
ligand binding, and light-driven catalysis. It is my hope that Ru(II)K115C-gsNOS may 
provide a useful platform for further investigation into the exciting and challenging 
catalytic cycle of NOS. 
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2.1 Introduction 
 Nitric oxide synthases (NOS) are a class of monooxygenase enzymes responsible 
for the catalytic production of nitric oxide radical (NO). NO is now recognized as an 
important biological molecule with many roles, such as an endothelial relaxing factor, a 
protective immunocytotoxin; and it is involved in neurotransmission and apoptosis.1–3 
There are three NOS isoforms found in mammals (mNOS) and NOS-like enzymes have 
now been discovered in all kingdoms of life, including archaea and bacteria.4 Bacterial 
NOSs share remarkably similar three-dimensional structures with their mammalian 
counterparts. It was initially surprising to find these enzymes in the bacteria themselves 
in part because NO is produced by macrophages during immune response to kill 
bacteria.5 The exact biological role for bacterially synthesized NO is still debated, but 
both in vitro and in vivo NO production have been demonstrated.6–8 In all cases, NOS 
catalyzes the three-electron oxidation of L-arginine (L-Arg) to L-citrulline (L-Cit) and NO 
in a two-turnover cycle. This reaction proceeds via the stable, enzyme-bound 
intermediate, N!-hydroxy-L-arginine (NOHA)3 (Scheme 2.1). 
 
Scheme 2.1 Overall reaction for the NOS-catalyzed production of NO and L-Cit starting 
with L-Arg, via the intermediate NOHA. The oxygen atom in both NO and L-Cit come 
from dioxygen; the nitrogen atom in NO is derived from the guanidinium nitrogen in L-
Arg.  
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mNOS functions as a homodimer consisting of an oxygenase domain linked to a 
reductase domain.9 The oxygenase domain houses a cysteine-ligated heme, as well as 
substrate and redox cofactor binding sites that create the active site of the enzyme. The 
calmodulin-linked reductase domain contains binding sites for flavin adenine 
dinucleotide (FAD), flavin mononucleotide (FMN), and nicotinamide adenine 
dinucleotide phosphate (NADPH).3 A general scheme for proposed full-length NOS 
domain connectivity and function can be found in chapter one. The reductase domain is 
the initial source of electrons for catalysis carried out at the oxygenase active site in 
mNOS. However, with one known exception,10 all bacterial NOSs lack a dedicated 
reductase domain; they have been shown to effectively utilize reductase domains from 
other systems.4 
The full mechanism by which NOS catalytically produces NO from L-Arg is still 
unknown,11 however steps can be borrowed from other members of the cysteine thiolate-
ligated heme enzyme superfamily to which it belongs. This family of monooxygenases 
that also includes chloroperoxidase (CPO) and the well-studied cytochromes P450, 
activates dioxygen (O2) to incorporate an oxygen atom into a variety of substrates.12 The 
first NOS turnover is a two-electron oxidation of L-Arg resulting in the hydroxylation of 
a guanidinium nitrogen in a reaction that is nearly identical to that of P450-catalyzed 
hydroxylation; the second turnover, a one-electron oxidation to form NO and L-Cit, is 
thought to follow a unique mechanism.11 The NOS resting state is a six-coordinate ferric-
aquo heme with an equilibrium of low- and high-spin states (“mixed-spin”). Substrate 
binding (L-Arg in the first cycle and NOHA in the second) in the pocket sterically 
displaces water to form a five-coordinate high-spin ferric state. Ferric NOS is reduced by 
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one electron originating from the reductase domain to give a ferrous species that can bind 
O2. Oxygen binding gives a ferrous-oxy species (often represented as a ferric-
superoxide), that is further reduced by one electron supplied by the redox-active cofactor 
(6R)-5,6,7,8-tetrahydrobiopterin (H4B, pterin).13 To date, the next experimentally 
observed species is the ferric resting state with bound NOHA. The second turnover shares 
similar steps: reduction, O2 binding, and reduction by H4B. From there, the next observed 
species is the NO-bound ferric heme, which then releases NO. The missing oxygenating 
intermediates are thought to be a ferryl porphyrin radical cation14 (analogous to 
compound I in P450) in the first turnover and either a hydroperoxo ferriheme15 or Cpd I 
formed by subsequent protonation/water loss in the second (Figure 2.1). 
 
Figure 2.1 Putative mechanism for the catalytic production of NO by NOS enzymes: (1) 
first turnover formation of NOHA from L-Arg, shown in blue path; (2) second turnover 
formation of L-Cit and NO radical from NOHA, shown in orange path. The proposed 
oxygenating intermediates are in brackets. 
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 In general, reactive species with very short lifetimes can only be observed if the 
reaction initiation is very fast, allowing time for intermediates to accumulate. 
Additionally, detection methods must be fast enough to “see” these transient species. One 
way to capture these types of elusive reactive intermediates is through rapid photo-
triggered electron transfer (ET), followed by transient absorption (TA) spectroscopy,16 
provided that each reaction component has a unique absorption feature (or a 
“spectroscopic handle”). The absorption properties of porphyrins, both in small molecule 
and heme-protein systems, are very sensitive to substrate/ligand binding and oxidation 
state.12 Changes in spin state and oxidation state are manifested in pronounced shifts in 
the Soret region, as well as in the Q-bands of hemes, and these shifts can be used to 
follow the progress of a given reaction. 
The Gray group has developed what is known as “flash-quench” methodology17 
to observe heme-based intermediates. Excitation (the “flash”) into the metal-ligand 
charge-transfer (MLCT) band of ruthenium(II)diimine photosensitizers, such as 
[Ru(bpy)3]2+ (bpy = 2,2’-bipyridine), creates an excited state ~2.1 eV above the ground 
state. Introduction of another small-molecule in solution (the “quench”) can lead to the 
formation of either a potent -1.3 V reductant, [Ru(bpy)3]1+, or +1.3 V oxidant, 
[Ru(bpy)3]3+.18 From there, electrons can either be injected into or pulled from the heme 
(Scheme 2.2).  
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Scheme 2.2 Flash-quench scheme showing both reductive and oxidative quenching 
routes. a) Reduction potentials are given for Ru(bpy)3 species in aqueous solutions18 b) 
Ru represents Ru(bpy)3, Q+ and Q- represent oxidative and reductive small molecule 
quenchers, respectively, Fe represents heme.  
 
 Previous work in the Gray group has found success with a flash-quench oxidation 
scheme using [Ru(bpy)3]2+ in solution which allowed access to Cpd I/II in horseradish 
peroxidase (HRP)19 and microperoxidase-8 (MP8).20 This approach was unsuccessful 
however, when applied to the more complex enzymes P450 and iNOS as their active sites 
are much more buried. We have shown that photosensitizers attached to substrate 
mimics21–23 can enter the active site and establish electronic communication with the 
heme; however they block the substrate binding channel preventing access to the full 
catalytic cycle, as well as excluding H2O and/or O2 needed to access Cpd I or II. Recent 
work with P450-BM3 has overcome these problems by covalently linking a 
photosensitizer to the surface of the protein, enabling through-bond ET without blocking 
the substrate channel.24 Flash-quench experiments using a reversible oxidative quencher 
led to observation of various porphyrn radical cation intermediates and Fe(IV)-hydroxide 
(protonated Cpd II). This was the first time a photochemically generated Cpd II has been 
observed in P450. 
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 In the continued effort to understand the mechanism by which NOS catalytically 
produces NO, we have chosen to study NOS from the thermostable, nonpathogenic 
bacterium Geobacillus stearothermophilus (gsNOS). gsNOS has a more constrained 
active site and slightly more compact overall fold as compared with other bacterial NOS-
like enzymes, however the three-dimensional structure is remarkably similar to other 
bacterial NOSs as well as mNOSoxy7 (see chapter one for a more detailed description). 
The enhanced thermal stability of this enzyme, as well as other unique properties, 
presents a convenient system to study the catalytic cycle. As gsNOS, like most bacterial 
NOS-like enzymes, lacks a dedicated reductase domain, we have the opportunity to 
supply electrons to the active site via a photosensitizer, thus sidestepping the need for a 
reductase domain entirely. Furthermore, covalent attachment of a ruthenium(II)diimine 
complex to the surface of the protein would enable electronic communication with the 
heme without blocking access to the substrate channel. 
 
2.2 Results and Discussion 
Preparation of gsNOS Mutant for Labeling 
Previous work in the Gray group has exploited surface histidines as labeling sites 
for various small molecule dyes and photosensitizers used in fluorescence energy transfer 
and ET experiments.16 gsNOS contains over a dozen surface exposed His residues, and it 
was thus determined that covalent labeling via a cysteine was more feasible. There are 
four native cysteines in gsNOS at positions 76, 161, 227, and 269. The sulfur of Cys76 
ligates the heme iron center of the active site and is necessary for heme incorporation and 
activity. Inspection of space-filling models reveals that Cys161 is thoroughly buried and 
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was thus left intact. The solvent-exposed residues Cys227 and Cys269 on the other hand, 
could present a problem in the selective labeling of gsNOS and were mutated to serine to 
prevent unwanted multiple labeling sites. Position 115 is natively a lysine residue and 
was determined to be a good candidate for mutagenesis and labeling: it is solvent-
exposed, close enough to the heme to provide reasonable electronic communication, and 
is located on the opposite side from the dimer interface so that the label does not interfere 
with the active dimer form of the protein (Figure 2.2). The plasmid for the triple mutant 
K115C/C227S/C269S (referred to as K115C-gsNOS) was constructed by site-directed 
mutagenesis, expressed in E. coli, and purified as described in the materials/methods 
section.  
        
Figure 2.2 Structure of gsNOS dimer highlighting residues important to the labeling 
construct; the four native cysteines are shown in orange and the lysine to be mutated to 
cysteine is shown in magenta. PDB code 2FLQ, figure was made with MacPymol 2009. 
 
 
! "#!
Labeling with a Ruthenium Photosensitizer  
The choice of a photosensitizer for protein labeling is important and one must 
consider the reduction potential, solubility in aqueous media, synthetic ease, and reactive 
moiety. Two major strategies have been employed in the Gray group for the attachment 
of a ruthenium (or rhenium) diimine complex: replacement of a pyridine ligand with the 
imidazole of a protein histidine residue16 or reaction of a cysteine sulfur with an alkyl 
halide linker to form a thioester bond.25 As mentioned earlier, gsNOS contains a large 
number of native histidines that could complicate selective labeling reactions. Previous 
attempts at labeling K115C-gsNOS have proven challenging and unreliable using the 
photosensitizer [Ru(bpy)2(Br-dmbpy)]2+ (Br-dmbpy = 4-bromomethyl-4’-methyl-2,2’-
bipyridine).26 It is not entirely clear why this complex was inefficient at labeling, but it is 
possible that the methyl-bromo group could not gain access to the cyseine due to linker 
length and/or rigidity or that bromide is not a good enough leaving group. We have had 
success using a longer and more flexible iodoacetamide linker for the attachment of 
organic fluorophores, such as Dansyl,25,27 to various proteins for energy transfer 
experiments. Recently that same linker scheme was used to attach a [Ru(bpy)2(IA-
phen)]2+ (IA-phen = 5-iodoacetamido-1,10-phenanthroline) complex to the surface of 
P450-BM3.24 Due to this previous work and the relatively straightforward synthetic 
route, we chose to use [Ru(bpy)2(IA-phen)]2+ for attachment to K115C-gsNOS.  
The labeling reaction with [Ru(bpy)2(IA-phen)]2+ was optimized over several 
attempts and protocols were established that gave consistent yields of ~60%, with 
unlabeled protein that can be pooled and saved for relabeling. The covalent attachment 
proceeds via an SN2 reaction to give the conjugate, Ru(II)K115C-gsNOS (Figure 2.3). 
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Unreacted label can be easily removed by filtration and the resultant labeled protein 
purified by fast protein liquid chromatography (FPLC). 
 
Figure 2.3 Illustration of K115C-gsNOS labeling reaction: the lone pair of electrons on 
the Cys115 sulfur attack the alkyl halide carbon releasing iodide as the leaving group in 
an SN2 reaction to give Ru(II)K115C-gsNOS via thioester linkage. 
 
 
Characterization 
 The labeled protein, Ru(II)K115C-gsNOS, was initially characterized by mass 
spectrometry (mass spec) and UV-visible absorption spectroscopy (UV-vis). Electrospray 
ionization (ESI) mass spec reliably confirmed the calculated mass of protein plus label 
(See Materials/Methods) and the absorption spectrum showed the expected shoulder from 
the [Ru(bpy)2(IA-phen)]2+ label (Figure 2.4). 
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Figure 2.4 UV-visible absorption spectra of unlabeled K115C-gsNOS, Ru(II)K115C-
gsNOS, and the [Ru(bpy)2(IA-phen)]2+  model complex. The six-coordinate low-spin 
ferric-aquo heme Soret maximum is at 403 nm, and the ruthenium photosensitizer-labeled 
protein shows a shoulder at 450 nm, as expected. 
  
 
Circular dichroism (CD) spectroscopy is a useful technique to determine the 
overall helical content and thermal stability of proteins.28 Chiral objects interact with 
circularly polarized light, and the resulting changes in polarity are measured as ellipticity. 
Proteins are made up of chiral amino acids, resulting in chiral tertiary structures such as 
!-helices and "-sheets, which give signature ellipticity in CD experiments. As a protein 
unfolds, these tertiary features are lost and result in CD signal changes. Unfolding curves 
can be generated by addition of a denaturant (urea or guanidinium chloride) or by 
increasing temperature, and the unfolding midpoint can be used to assess the overall 
stability of the system. The helical content of both the K115C-gsNOS mutant and the 
labeled protein, Ru(II)K115C-gsNOS, were assessed by CD spectroscopy (Figure 2.5-a). 
Both proteins share almost identical spectral features in the full wavelength scan, 
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characteristic of a predominantly !-helical structure. One of the appeals to working with 
gsNOS is that it is so thermally stable. Wild type (w.t.) gsNOS has a melting midpoint of 
approximately 80 °C that is about 20 degrees higher than the average bacterial NOS.7 The 
temperature-induced unfolding curves (or melting curves) are also quite similar (Figure 
2.5-b), both to each other and to w.t. gsNOS. The midpoints for both labeled and 
unlabeled NOS are approximately 75 °C and are in good agreement with previously 
measured w.t. gsNOS.7,26 These experiments were initial indicators that both the mutation 
and the subsequent labeling did not significantly alter the overall fold and stability of 
gsNOS. 
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Figure 2.5 Circular dichroism measurements comparing K11C-gsNOS and Ru(II)K115C-
gsNOS: a) wavelength scan at room temperature to qualitatively assess overall helical 
content; b) temperature-induced unfolding curves showing nearly identical thermal 
stability (ellipticity was recorded at the !-helical maximum of 220 nm while increasing 
temperature). 
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X-ray Crystallography 
 In collaboration with the Crane lab at Cornell University, the X-ray crystal 
structure of our labeled Ru(II)K115C-gsNOS conjugate has been solved to a resolution of 
2.6 Å. There is one monomer in the unit cell belonging to the space group P3221 with the 
dimer interface at the edge of the unit cell (as seen in w.t. gsNOS). The structure is 
remarkably similar to w.t. gsNOS. It maintains all of the major !-helices, including the 
helical T and lariat at the interface, and the conserved "-winged core.4 While there are 
certain areas containing more disorder and flexibility, overlay of the structures indicates 
that the [Ru(bpy)2(A-phen)]2+ label does not substantially perturb the overall structure 
(Figure 2.6). 
 
Figure 2.6 Structure of the Ru(II)K115C-gsNOS dimer (subunits are in cyan and grey) 
showing overall fold including helical lariet and T motif. One subunit is overlayed with 
w.t. gsNOS (shown in green). The [Ru(bpy)2(A-phen)]2+ label is shown in pink and the 
hemes in green. w.t. PDB code 2FLQ, figure was made with MacPymol 2009. 
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 There are a few noticeable differences compared to w.t. gsNOS. However it 
should be noted that the structure of Ru(II)K115C-gsNOS was solved in the absence of 
substrate and cofactor, whereas w.t. gsNOS was solved with L-Arg bound. One area of 
interest is in the region of Glu248 – Met262, which includes a portion of the H4B binding 
site. Since bacterial NOS enzymes lack the typical mammalian H4B binding loop, the 
H4B cofactor is instead bound using key residues at the dimer interface.4 In gsNOS, these 
are Phe347 and Trp332 in one subunit and Arg252 and Trp334 on the other. The 
Ru(II)K115C-gsNOS structure shows more flexibility in the loop adjacent to the helix 
containing Arg252. This seems to manifest as slightly rotated amino acid side chains, 
including that of Arg252 itself, however the other binding partner in that subunit 
(Trp334) is basically unchanged (Figure 2.7-a). 
Key residues in the heme active site are preserved in the Ru(II)K115C-gsNOS 
structure. The two NO-release “gate” residues (His134 and Ile223)29,30 are unchanged in 
this structure as is the conserved Trp70 (see chapter one for relevant discussion). The 
heme position is mostly the same, however it is slightly rotated and one of the heme 
propionates is bent out of the plane in this structure (Figure 2.7-b). 
Note: Crystals of L-Arg-bound Ru(II)K115C-gsNOS have now been grown and a 
data set has been collected, however the structure has not yet been refined. It will be 
interesting to see if the presence of substrate imparts more order on the structure. 
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Figure 2.7 Comparison of Ru(II)K115C-gsNOS (cyan) and w.t. gsNOS (green) structures. 
a) Overlay of H4B binding site showing disorder in the Glu248 – Met262 region causing 
changes at Arg252 (portions of the protein were removed for clarity) and b) Overlay of 
the active site showing no significant changes at the “gate residues” or at Trp70. One of 
the heme propionates is substantially bent out of the plane and is circled in orange. Figure 
was made with MacPymol 2009. 
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 The distance between the Ru atom of the label and the Fe of the heme is 25 Å 
(Figure 2.8) in the crystal structure of Ru(II)K115C-gsNOS. The label is extended away 
from the protein surface and the carbonyl of the linker does not appear to hydrogen bond 
with any of the possible neighboring residues (such as Lys298, R117, or N112). 
However, there was considerable disorder associated with the [Ru(bpy)2(A-phen)]2+ label 
itself, presumably due to the flexible iodoacetamide linker, as seen with ruthenium-
labeled P450-BM324 (PDB 3NPL). It is possible that the label is actually much closer to 
the heme when the enzyme is in solution; there is an open pocket containing the surface-
exposed Trp243 that could provide !-stacking interactions with the bipyridine or 
phenanthroline groups of the label. This type of interaction or other hydrophobic 
interactions with the surface would shorten the Ru-Fe distance by up to 10 Å.  
    
Figure 2.8 Structure of Ru(II)K115C-gsNOS. The covalent attachment of  [Ru(bpy)2(A-
phen)]2+ at the nonnative Cys115 gives a distance of 25 Å between the Ru and Fe atoms. 
Surface-exposed Trp243 is shown in green. Figure was made with MacPymol 2009.  
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Electron Transfer Calculations 
 The goal of preparing this ruthenium-modified gsNOS was to trigger 
photoinduced heme reduction and thus bypass the need for a reductase domain. As such, 
it is worthwhile to briefly discuss the general principles of electron tunneling through 
proteins to predict ET rates in the present system. Non-adiabatic ET between a redox 
donor (D) and acceptor (A) held at a fixed distance can be described by the following 
semi-classical Marcus expression:31 
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where !G° is the driving force and ! is the reorganization parameter that reflects the 
energy of nuclear reorganization in the charged state. ! is largely affected by the protein 
fold and can be sufficiently lowered by keeping the redox site buried from aqueous 
solvent. The electronic coupling matrix element, HAB, is a measure of the strength of 
interaction between the reactants and products at the transition state and is predicted to 
decrease exponentially with increasing distance (r) between redox partners: 
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                  (eqn 2.2)  
where r0 is the close-contact D-A distance and " is the distance decay factor describing 
the ability of a particular medium to facilitate ET. Large values of " result in coupling 
that is strongly distance dependent (e.g., " = 2.9–4.0 Å-1 for ET through a vacuum32), 
whereas small values of " result in D-A coupling interactions that are largely distance 
independent (e.g., " ~0.4–0.8 Å-1 for ET through conjugated polymers33,34).  
Over the past three decades, the Gray group has been interested in understanding 
long-distance electron tunneling kinetics in proteins35 and model systems.32 ET through 
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various ruthenium-modified proteins, as well as other media, have been extensively 
studied and the results can be summarized in tunneling timetables (Figure 2.9).  This 
work allowed very reasonable estimations of ! and " values for ET through proteins. 
         
Figure 2.9 a) Timetable for activationless ET in various media. It is of interest to 
compare the extracted distance dependency (" =1.0 Å-1) of alkane-bridged D-A systems 
(orange line) with those of proteins; b) Tunneling timetable for intraprotein ET in Ru-
modified proteins which fall mainly on the " =1.0 Å-1 line. Figure replicated from Gray.32 
 
 
 From here we can calculate the rate for heme reduction by Ru(I) in our 
Ru(II)K115C-gsNOS system using the Marcus equation with the estimates " = 1.1 Å-1 and 
! = 0.8eV.35 The driving force can be calculated from the reduction potentials for  
[Ru(bpy)2(A-phen)]2+ (estimated from Ru(bpy)3) and K115C-gsNOS (estimated from 
wild type gsNOS):  
RuI   !   RuII  +  e-,    E° = +1.30 V (vs. NHE)18             (eqn 2.3) 
FeIII  +  e-   !   FeII,  E° = -0.360 V (vs. NHE)26             (eqn 2.4)  
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Taking !G° = +0.940 V and the Ru-Fe distance of 25 Å from the X-ray crystal structure, 
we get a rate of kET ~ 2.5 x 102 s-1. However, if we assume that the [Ru(bpy)2(A-phen)]2+ 
label is actually tucked in against the protein surface in solution, a Ru-Fe distance of 15–
18 Å might be more reasonable. These distances yield a range of rates from kET ~ 1.5 x 
107 s-1 to kET ~ 5.5 x 105 s-1 with time constants (!ET) from 60 ns to 2 µs. The calculated 
driving force (!G°) and arrangement of redox partners indicates that rapid electron 
injection is possible to reduce the heme in Ru(II)K115C-gsNOS. 
 
2.3 Conclusion 
 We have used site-directed mutagenesis to install a single surface cysteine at 
position 115 on gsNOS for selective labeling with [Ru(bpy)2(IA-phen)]2+. The resultant 
conjugate, Ru(II)K115C-gsNOS, has been characterized in terms of electronic structure and 
thermal stability.  Ru(II)K115C-gsNOS has been crystallized and the structure solved to a 
resolution of 2.6 Å. The crystal structure shows increased flexibility in the H4B binding 
region as compared to w.t. gsNOS. One of the heme propionates is bent out of the plane, 
however the positions of key residues in the active site are unchanged. Overall the 
structure of Ru(II)K115C-gsNOS does not appeared significantly perturbed due to 
attachment of the [Ru(bpy)2(IA-phen)]2+ label. While the crystal structure shows a fully 
extended label-linker with a Ru-Fe distance of 25 Å, a shorter distance is more likely in 
solution as the label can associate with the protein surface. Electron transfer rates have 
been estimated depending on actual Ru-Fe distance, with more reasonable rates in the 
range of kET ~ 1.5 x 107 s-1 to kET ~ 5.5 x 105 s-1 . With this system in hand, we can photo-
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trigger electron injection to reduce the gsNOS heme and explore the biological route of 
the catalytic cycle. 
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2.5 Materials and Methods 
General 
Chemicals were used as purchased unless otherwise noted. All buffers were made 
with Milli-Q water (18.2 M!) and filtered (0.22 µm, Millipore) before use. Molecular 
biology was carried out using sterile techniques and all media/glassware was prepared by 
autoclave before use. 
Protein Preparation 
The w.t. plasmid for gsNOS (pETDuet vector, Novagen) was a generous gift from 
Professor Brian Crane. The vector encodes for chloramphenicol resistance and a 
thrombin-cleavable His6-tag for protein purification. The desired triple mutant 
K115C/C227S/C269S (K115C-gsNOS) was prepared using site-directed mutagenesis 
(QuikChange Kit, Stratagene); primers were designed according to standards outlined in 
the kit and purchased from Operon. The mutant plasmid was transformed into competent 
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cells for DNA cloning following standard procedure (XL1 Blues, Stratagene) and 
sequenced (Laragen).  The variant was then transformed into BL21 (DE3) competent 
cells (Invitrogen) and glycerol cell stocks were prepared for later expression.  
His6-K115C-gsNOS was expressed following published procedures for w.t. 
gsNOS,7 with minor changes. 3 x 50 mL of culture media (LB and 50 µL of 34 mg/mL 
stock of chloramphenicol in ethanol) was inoculated from glycerol cell stocks of BL21 
(DE3) cells containing the His6-K115C-gsNOS pETDuet plasmid. After overnight 
incubation at 37 °C with shaking at 180 rpm, the starter cultures were used to inoculate 
9L of media (LB and 1mL/L chloramphenicol stock). After approximately 3 hours of 
incubation at 37 °C with shaking at 180 rpm, the OD600nm reached 1.0–1.4, and 
expression was induced with an aqueous solution of iron(III)chloride, isopropyl !-D-1-
thiogalactopyranoside (IPTG), and "-aminolevulinic acid to final media concentrations of 
125 mg/L, 100 µM, and 50 mg/L, respectively (note— if you make this solution with all 
three components, make sure to dissolve FeCl3 in water first and let it cool to room 
temperature before adding IPTG and "-aminolevulinic acid). After overnight growth 
(approximately 20 hours), cells were pelleted by centrifugation at 5,000 rpm and then 
frozen at -20 °C for at least two hours.   
His6-K115C-gsNOS was extracted and purified as follows. Cells were 
resuspended in 100 mL of lysis buffer (25 mM HEPES, pH 7.5, 5 mM imidazole, 
500mM NaCl) along with microspatula tips of four protease inhibitors (Bestatin, 
Leupeptin, pefabloc SC, and benzamidine). The suspension was sonicated on ice for a 
total of 10 min (0.5 sec on/0.5 sec off) and centrifuged for two hours at 16,000 rpm. The 
supernatant was filtered with a 0.22 µm syringe filter (Millipore) and loaded onto an 
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FPLC nickel-chelating column (3 x 5 mL HisTrap, GE Healthcare). The column was 
washed with buffer (25 mM HEPES, pH 7.5, 10 mM imidazole, 500 mM NaCl) until 
absorbance returned to baseline (approximately 100 mL) and His6-K115C-gsNOS was 
eluted with a single step (0% –100%) to a buffer containing 300 mM imidazole.  
The His6-tag was cleaved with 100 µL bovine thrombin (Calbiochem, stock 
prepared according to product instructions) for at least 4 hours at 4 °C with gentle 
shaking. K115C-gsNOS was concentrated to 2.5 mL via centrifugation using a 30,000 
MW cutoff spin filter (Millipore) and loaded onto a size exclusion column (HiLoad 26/60 
Superdex 200pg, GE Healthcare). Protein was eluted with a constant flow rate of 1.6 
mL/min into 50 mM Tris, pH 7.5, 150 mM NaCl (Figure 2.10). The FPLC fractions were 
submitted for mass spec, then pooled and concentrated (Figure 2.11). The calculated 
mass (protein + heme) = 44,490 amu. K115C-gsNOS concentration was determined by 
absorbance at 400 nm (! ~ 80,000 M-1 cm-1).26 
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Figure 2.10 Typical FPLC chromatogram for K115C gsNOS purification by size 
exclusion chromatography; monitored by absorbance at 280 nm (aromatic amino acids) 
and 400 nm (heme Soret); elution buffer held constant throughout. First and last small 
shoulders were discarded. 
 
          
Figure 2.11 ESI mass spectrum of purified K115C gsNOS, showing single major peak at 
43,870.6 (note— heme does not fly with gsNOS so the calculated mass will add 618 
amu). 
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Synthesis of [Ru(bpy)2(IA-phen)]2+ Label 
Ruthenium(II) bisbipyridine 5-iodoacetamido-1,10-phenanthroline ([Ru(bpy)2(IA-
phen)]2+) was synthesized according to published procedure36 with the following 
modification: the aminophenanthroline ligand was coordinated to Ru(bpy)2 before 
converting the amino group to iodoacetamido (Scheme 2.3). 
 
Scheme 2.3 Synthesis of [Ru(bpy)2(IA-phen)]2+ : 1) reflux in MeOH, 3 hours; 2) CH3CN, 
overnight at room temp. 
 
Briefly, Ru(bpy)2Cl2 and a 10-fold molar excess of 5-amino-1,10-phenanthroline 
were refluxed in methanol for 3 hours with stirring. The solution was cooled to room 
temperature and filtered. The product (1) was precipitated by addition of concentrated 
aqueous NH4PF6 and the solid collected on a medium frit. The solid was washed with 
water, followed by cold ether, and dried in air. The PF6 salt of (1) and a 5- to 10-fold 
molar excess of iodoacetic anhydride were dissolved in acetonitrile and allowed to react 
at room temperature overnight with stirring. The product crystallized and was washed 
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with cold sodium bicarbonate, followed by water, before being dried over vacuum (note: 
if the product does not crystallize on its own, additional NH4PF6 can be added here). The 
product was a crystalline red powder and only sparingly soluble in water. Mass spec 
confirmed a molecular weight of 776.1 and showed the characteristic ruthenium isotope 
pattern. The UV-vis spectrum is nearly identical to that of Ru(bpy)32+ with characteristic 
double hump at 428 and 465 nm.37 
Labeling Reaction 
Immediately prior to labeling, K115C-gsNOS was reduced with excess 
dithiothreitol (DTT) to break up any disulfide bonds that may have formed between the 
exposed cysteines of two proteins. After 30 min, DTT was removed from the reduced 
protein with a HiTrap Desalting column (GE Healthcare) into 20 mM Tris buffer, pH 8. 
The protein concentration was determined by absorbance at 400 nm (! ~ 80,000 M-1 cm-1) 
and then further diluted with Tris to approximately 20 mL of 10 µM protein. An initial 
spectrum was recorded and the starting absorbance at 450 nm was noted. 
Due to the insolubility of the [Ru(bpy)2(IA-phen)]2+ label, a spatula tip of 
complex was initially dissolved in 1 mL dimethyl sulfoxide (DMSO) and then brought up 
to 3 mL with dropwise addition of water. In the dark (from here on, any samples 
containing photosensitizer-labeled protein were stored in the dark and worked with under 
minimal or red light), the resulting bright yellow/orange solution was slowly added to the 
protein until the concentration of label reached approximately 10-fold excess of protein. 
UV-vis spectra were recorded periodically to calculate the concentration of label by 
difference in absorbance at 450 nm (! ~ 15,000 M-1 cm-1, estimated from Ru(bpy)3Cl2 in 
water).38 The reaction was covered in foil and gently shaken for 3 hours at room 
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temperature (or 4 hours at 4 °C). To stop the reaction, DTT was added and the mixture 
was desalted again into 20 mM Tris, pH 8 to remove DTT and any unreacted label.  
The labeled and unlabeled proteins were separated by FPLC equipped with a 
FastFlow Q sepharose anion exchange column (5 mL, GE Healthcare) (Figure 2.12). In 
the dark, the protein mixture was loaded onto the column and washed with at least 5 
column volumes of starting buffer (or until baseline). The proteins were eluted at a flow 
rate of 4 mL/min with a salt gradient of 12% –32% elution buffer (20 mM Tris, 1 M 
NaCl, pH 8) over 360 mL. Absorbance was monitored at 280, 400, and 450 nm. The 
labeled protein contains a larger overall positive charge and eluted first.  
 
Figure 2.12 Typical FPLC chromatogram for separation of labeled and unlabeled protein 
using anion exchange chromatography; monitored by absorbance at 280 nm (aromatic 
amino acids), 400 nm (heme Soret), and 450 nm (Ru label); gradient line = increasing 
NaCl concentration. First peak corresponds to Ru labeled gsNOS, second peak was 
mostly unlabeled and kept for later labeling attempts. 
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UV-vis spectra were recorded for representative fractions, which were then 
submitted for mass spec analysis before pooling (Figure 2.13). Fractions containing 
unlabeled protein were pooled and saved for future labeling reactions. Fractions 
containing pure labeled protein were pooled and concentrated to approximately 100 µM 
by centrifugation using Amicon spin columns with 30,000 MW cutoff filters. The typical 
yield for pure Ru(II)K115C-gsNOS was 60% –70 %. Stocks were wrapped in foil and 
stored at 4 °C for use within two weeks or aliquots were flash-frozen in liquid nitrogen 
and kept at -20 °C for long-term storage. 
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a) 
 
b) 
 
 
Figure 2.13 ESI mass spectra for Ru(II)K115C-gsNOS anion exchange column fractions: 
a)  early fractions showing single peak corresponding to mass of K115C-gsNOS (minus 
heme) plus the mass of the ruthenium label (minus iodide) (calc ~44,520 amu); b) middle 
fraction showing mixed peaks for both labeled and unlabeled protein. 
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Crystallography 
 Ru(II)K115C-gsNOS crystals were grown under the following conditions: 0.5 µL of 
400 µM protein in Wizard III (Emerald BioSystems) well condition #31 containing 70 
mM sodium acetate buffer, pH 4.7, 70 mM calcium chloride, 30% glycerol, and 17% 
isopropanol. Crystals took an average of 2–3 weeks to grow (Figure 2.14). Diffraction 
data were collected at the Cornell High Energy Synchrotron Source (CHESS) beamline 
A1 (http://www.chess.cornell.edu/chess/west/A1.htm). Due to the high concentration of 
isopropanol present, no additional cryportectants were used.  
 
Figure 2.14 Ru(II)K115C-gsNOS crystallization a) crystals after 3 weeks b) raw diffraction 
data collected at CHESS. 
 
 Data were indexed and scaled using HKL2000 (HKL Research). Molecular 
replacement and initial refinement were achieved using Python-based Hierarchical 
ENvironment for Integrated Xtallography (Phenix) and all other refinement steps using 
CNS (Crystallography and NMR System, CNSsolve). Data collection and preliminary 
refinement information are given in Table 2.1. 
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Table 2.1 Crystallographic data and partial refinement statistics for Ru(II)K115C-gsNOS  
Wavelength (Å) 0.987 
Unit Cell Parameters  
a,b,c (Å) 90.047, 90.047, 112.118 
!,",# (deg) 90, 90, 120 
Space Group P3221 
Diffraction Resolution (Å) 1.98 
Refinement Resolution (Å) 2.6 
RFree 0.244 
RWork 0.241 
Completeness  
at 2.6 Å 85 % 
at 3.2 Å 100 % 
 
Instrumentation 
Protein purification by Fast Protein Liquid Chromatography (FPLC) was carried 
out using an Akta Purifier from GE Healthcare. Protein mass was recorded using 
Electrospray Ionization (ESI) spectrometry by the Protein/Peptide MicroAnalytical 
Laboratory (PPMAL) in the Beckman Institute at the California Institute of Technology. 
[Ru(bpy)2(IA-phen)]2+ mass was recorded using a Finnigan LCQ ion trap mass 
spectrometer. UV-visible absorption spectra were recorded on an Agilent 8453 UV-vis 
Spectrophotometer; measurements were made in 1 cm pathlength quartz cuvettes (from 
Starna Cells) and background subtracted using appropriate buffer solutions. Circular 
dichroism data were acquired using an Aviv Model 62ADS Spectropolarimeter equipped 
with a thermostated sample holder; measurements were made in 1 mm pathlength 
cuvettes (Starna Cells).  
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3.1 Introduction 
 Nitric oxide (NO)1,2 is a biological signaling molecule produced by a class of 
enzymes aptly named nitric oxide synthases (NOS).3 There are three NOS isoforms found 
in mammals (mNOS),4 and NOS-like enzymes have now been discovered in all 
kingdoms of life, including archaea and bacteria.2 NOS catalyzes the five-electron 
oxidation of L-arginine (L-Arg) to L-citrulline (L-Cit) and NO in two turnovers, 
proceeding via the stable, enzyme-bound intermediate, N!-hydroxy-L-arginine (NOHA).5 
The overall reaction is summarized in Scheme 3.1. 
             
Scheme 3.1 Overall reaction for NOS-catalyzed production of NO and L-Cit starting with 
L-Arg, via the intermediate NOHA. The oxygen atom in both NO and L-Cit come from 
dioxygen; the nitrogen atom in NO is derived from the guanidinium nitrogen in L-Arg.  
 
All isoforms of NOS function as homodimers and share nearly identical active sites 
containing a cysteine-ligated heme, as well as substrate and redox cofactor binding sites. 
However there are some noteworthy differences between mNOS and bacterial NOS. The 
most striking difference is that mNOSs have a linked reductase domain,6 but all but one 
bacterial NOS lack any dedicated NADPH-dependent reductase domain.7 Details about 
the domains of mNOS and structural differences in bacterial NOS are described in 
chapter one of this thesis. 
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Some of the discrete steps by which NOS produces NO from L-Arg are still 
unknown,4 however steps can be borrowed from other members of the cysteine thiolate-
ligated heme enzyme superfamily to which it belongs. This family of monooxygenases 
includes chloroperoxidase (CPO) and the well-studied cytochromes P450. Like NOS, 
these enzymes activate dioxygen (O2) to incorporate an oxygen atom into a variety of 
substrates.8 The first NOS turnover is a two-electron oxidation of L-Arg resulting in the 
hydroxylation of a guanidinium nitrogen to yield NOHA in a reaction that is reminiscent 
of P450-catalyzed hydroxylations. The second turnover, a one-electron oxidation to form 
NO and L-Cit, is thought to follow a unique mechanism.9 The NOS resting state is a six-
coordinate ferric-aquo heme with an equilibrium of low- and high-spin states (“mixed-
spin”). Substrate binding (L-Arg in the first cycle and NOHA in the second) in the pocket 
sterically displaces water to form a five-coordinate high-spin ferric state. Ferric NOS is 
reduced by one electron from the reductase domain to give a ferrous species that can bind 
O2. Oxygen binding gives a ferrous-oxy species (often represented as a ferric-
superoxide), that is further reduced by one electron supplied by the redox-active cofactor 
(6R)-5,6,7,8-tetrahydrobiopterin (H4B).10 To date, the next experimentally observed 
species is the ferric resting state with bound NOHA. The second turnover shares similar 
steps: reduction, O2 binding, and reduction by H4B. From there, the next observed species 
is the NO-bound ferric heme, which then releases NO. The missing oxygenating 
intermediates are thought to be a ferryl porphyrin radical cation11 (analogous to 
compound I in P450) in the first turnover and either a hydroperoxo ferriheme12 or Cpd I 
formed by subsequent protonation/water loss in the second11 (Figure 3.1). 
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Figure 3.1 Putative mechanism for the catalytic production of NO by NOS enzymes: (1) 
first turnover formation of NOHA from L-Arg, shown in blue path; (2) second turnover 
formation of L-Cit and NO radical from NOHA, shown in orange path. The proposed 
oxygenating intermediates are shown in brackets. 
 
 In general, reactive species with very short lifetimes can only be observed if the 
reaction initiation is very fast, allowing time for intermediates to accumulate. 
Additionally, detection methods must be fast enough to “see” these transient species. One 
way to capture these types of elusive reactive intermediates is through phototriggered 
electron transfer (ET), followed by transient absorption (TA) spectroscopy,13 provided 
that each reaction component has a unique “spectroscopic handle,” such as an absorption 
feature. The absorption properties of porphyrins, both in small molecule and heme-
protein systems, are very sensitive to substrate/ligand binding and oxidation state.8 
Changes in spin state and oxidation state are manifested in pronounced shifts in the Soret 
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region and in the Q-bands of hemes, and these shifts can be used to follow the progress of 
a given reaction. For example, the w.t. gsNOS resting state is a six-coordinate, mixed-
spin heme with water occupying the 6th site in the distal pocket and the Soret maximum is 
at 403 nm. Introduction of the L-Arg substrate displaces the water resulting in a five-
coordinate, high spin complex and the Soret band sharpens and shifts to 399 nm. 
Chemical reduction to give the five-coordinate ferrous species results in a red-shifted 
Soret maximum at 415 nm (Figure 3.2).14 These species have all been prepared under 
steady state conditions providing convenient spectroscopic handles with which to watch 
the cycle in action. Transient measurements involve exciting the sample with a laser 
pulse while simultaneously probing with white light to give time-resolved absorption 
information. These experiments can be set up to either detect the entire spectrum at a 
fixed time delay after excitation or to measure absorbance as a function of time at a single 
wavelength.  
      
Figure 3.2 UV-visible absorption of wild type gsNOS showing characteristic Soret shifts 
upon substrate binding and changes in oxidation state. Soret maxima for substrate-free 
ferric state (403 nm), L-Arg-bound ferric (399 nm), imidazole-bound ferric (427 nm), and 
chemically reduced ferrous (415 nm). Figure replicated from Sudhamsu.14 
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 As described in chapter one, “flash-quench” methodology can be employed to 
photoinduce reduction or oxidation.15 Briefly, laser excitation (the “flash”) into the metal-
ligand charge-transfer (MLCT) band of a ruthenium(II)diimine photosensitizer creates an 
excited state approximately 2.1 eV above the ground state. This excited state can be 
“quenched” by an appropriate small molecule in solution yielding either a potent -1.3 V 
reductant, [Ru(bpy)3]1+, or +1.3 V oxidant, [Ru(bpy)3]3+,16 that can then inject or extract 
electrons from the system of interest (in this case, gsNOS heme). The resultant reduced or 
oxidized heme will have a shifted Soret band (Figure 3.2). TA data collected at a 
particular wavelength in the Soret region over time can show either a signal increase 
(positive change in optical density, !OD > 0) or a signal decrease (often referred to as a 
“bleach,” !OD < 0). Carefully fitting these signal changes to kinetics models can yield 
valuable information about the rates of individual steps in a given reaction. 
 Researchers in the Gray group have successfully observed the ferryl porphyrin 
radical cation (Cpd I) and ferryl species (Cpd II) in both horseradish peroxidase (HRP)17 
and microperoxidase-8 (MP8)18 using oxidative flash-quench techniques with 
[Ru(bpy)3]2+ in solution. Applications of this technique to P450 and iNOS were 
unsuccessful probably because of weak electronic coupling between the solution 
photosensitizer and the much more buried hemes of these enzymes. Subsequent studies 
with photosensitizers linked to substrate mimics were successful in heme 
photoreduction.19–21 These “wires” penetrate the substrate-binding channels to engage in 
ET with the active site, however they effectively block the distal pocket, preventing 
access to later steps in the catalytic cycle, as well as H2O/O2 binding necessary to access 
Cpd I. 
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Recent work with P450-BM3 circumvented the aforementioned problems by 
covalently attaching a Ru(II)diimine photosensitizer to the protein surface, enabling 
through-bond ET without blocking the substrate channel.22 Oxidative flash-quench was 
used to rapidly pull an electron from the Fe(III) resting state, generating one-electron 
oxidized porphyrin radical cation intermediates. TA spectroscopy was used to observe 
these transient species, allowing the assignment of one high-valent intermediate as 
Fe(IV)-hydroxide (protonated Cpd II). This was the first time a photogenerated Cpd II 
has been seen in P450. The kinetics of formation and disappearance of these 
intermediates were complex over the microsecond to second range. Singular value 
decomposition analysis of the TA data pointed to at least five distinct phases (Figure 3.3-
a), suggesting that six species form after laser excitation. The first and second were 
identified as the *Ru(II)-Fe(III) excited state and the oxidatively quenched Ru(III)-Fe(III) 
species, respectively. The final species was assigned to the original Ru(II)-Fe(III) resting 
state, leaving three distinct intermediates to be determined by modeling. A scheme for the 
sequential kinetics model used for the heme oxidation of Ru(II)-P450-BM3 is shown in 
Figure 3.3-b.  
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Figure 3.3 Photogenerated formation of compound II in P450-BM3 a) Representative 
single-wavelength TA data at 420 nm for Ru(II)-Fe(III)P450 (blue) and model complex 
(yellow), both with oxidative quencher. Circled numbers correspond to the beginning of 
each phase. b) Diagram of the model for photochemical heme oxidation used in TA 
kinetics analysis. Figure replicated from Ener.22 
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 Taking a page from the P450 book, we have used site-directed mutagenesis to 
install a single surface cysteine at position 115 in gsNOS for selective labeling with 
[Ru(bpy)2(IA-phen)]2+ (where bpy = 2,2’-bipyridine and IA-phen = 5-iodoacetamido-
1,10-phenanthroline). The resultant conjugate, Ru(II)K115C-gsNOS, has been characterized 
in terms of electronic structure and thermal stability. Additionally, the labeled protein has 
been crystallized and the structure solved to a resolution of 2.6 Å. In contrast to the 
previously described work on P450-BM322 which aimed to directly oxidize the heme, our 
goal here was to explore the biological route of the catalytic cycle by phototriggering 
electron injection to reduce the gsNOS heme (Scheme 3.2). Initial calculations based on 
semi-classical electron transfer theory predict that reduction with Ru(I) can occur in the 
timescale range of 60 ns to 1 µs depending on the actual position of photosensitizer 
bound to gsNOS in solution. A detailed description of protein expression, ruthenium label 
synthesis, labeling reaction, characterization, and ET calculations can be found in chapter 
two of this thesis. 
  
Scheme 3.2 Reductive flash-quench scheme for heme reduction in gsNOS. Ru represents 
[Ru(bpy)2(IA-phen)]2+ attached to gsNOS, Q represents the quencher MeODMA, and Fe 
represents gsNOS heme. Note: the reductively quenched excited state may be better 
described as a Ru(II)(ligand•+), but we will simply use “Ru(I)” here. 
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3.2 Results and Discussion 
Reductively Quenching the Model Complex [Ru(bpy)2(A-phen)]2+ 
 In order to investigate the reductive path of the NOS catalytic cycle, we needed a 
water-soluble, reversible quencher capable of reducing the *Ru(II) excited state to form 
Ru(I) (this species may actually be Ru(II)(ligand•+), but will be referred to as “Ru(I) in 
this text), a species capable of injecting an electron into the heme of gsNOS. The organic 
small molecule quencher, p-methoxy-N.N-dimethylanaline (MeODMA), has been 
previously used in the Gray group for flash-quench experiments.23 Reaction of this 
quencher with the excited state of a ruthenium(II) diimine complex results in the 
formation of a MeODMA radical cation, which has its own transient absorption features. 
Initial controls were performed to independently monitor this quencher species to ensure 
that it does not interfere with the TA signals of interest, namely the heme Soret of gsNOS 
(data not shown, but described elsewhere24). 
In order to distinguish between signals arising from the more complicated labeled 
protein system and the ruthenium label itself, photophysical properties of the model 
complex [Ru(bpy)2(A-phen)]2+ (where A-phen = 5-acetamido-1,10-phenanthroline)  were 
measured both in the absence and presence of the MeODMA quencher. As expected, the 
*Ru(II) excited state is luminescent with an emission maxiumum centered around 630 
nm. Following 480 nm laser excitation into the tail of the Ru(II) MLCT band, the *Ru(II) 
luminescence decay is described by a monoexpoenential with a lifetime on the order of ! 
~ 1 µs. Upon introduction of excess MeODMA, the luminescence decay at 630 nm is 
faster with a pseudo first-order rate constant of k = 1.7 x 107 s-1, which corresponds to a 
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time constant (!) of 58 ns. These data suggest effective quenching and provide a rate of 
Ru(I) formation. 
TA spectroscopy was used to monitor the absorbance changes corresponding to 
the *Ru(II) electronic excited state, the quenched formation of Ru(I), and recombination 
to form the Ru(II) ground state of the [Ru(bpy)2(A-phen)]2+ model complex. The Ru(II) 
ground state has absorbance bands in the 400–500 nm region which are sensitive to 
oxidation state: the *Ru(II) excited state has markedly less absorbance in that region and 
the Ru(I) species has only slightly weaker absorbance than Ru(II). In the absence of 
MeODMA, the formation of *Ru(II) monitored at 440 nm results in a nearly 
instantaneous negative optical density (a “bleach”) followed by a return to baseline with a 
rate matching that of the *Ru(II) luminescence decay (Figure 3.4-a). In the presence of 
quencher, the same initial bleach is observed. A fast increase of absorbance to a very 
slightly negative overall !OD occurs with a rate matching that of the quenched 
luminescence decay, suggesting the formation of Ru(I). Recombination with the 
MeODMA radical cation results in a slower return to baseline (Figure 3.4-a). These 
single-wavelength TA signals were monitored at various wavelengths between 400 and 
440 nm and representative traces are shown in Figure 3.4-b. Measurements at longer 
wavelengths (from 410 to 440 nm) show an unexpected further increase in !OD 
developing at longer timescales (~100 µs). We do not have a definitive assignment for 
this species, however it seems likely that some of the transiently formed MeODMA 
radical cation forms other products (e.g., dimerization).23 Additionally, solutions of 
MeODMA left overnight under ambient light undergo uncharacterized side reactions as 
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indicated by development of pink color. All further experiments were done in minimal or 
red light, using freshly made solutions. 
  
Figure 3.4 Transient absorption traces for the model complex [Ru(bpy)2(A-phen)]2+: a) 
comparison of TA at 440 nm for Ru(bpy)2(A-phen)]2+ (+/- MeODMA quencher); b) TA 
of quenched model complex at representative wavelengths (420 and 440 nm) showing 
initial bleach from *Ru(II), formation of Ru(I), and unassigned positive !OD at longer 
timescales. [Ru(bpy)2(A-phen)]2+] = 8 µM and [MeODMA] = 8 mM, 50 mM sodium 
phosphate buffer, pH 7. 
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Photoreduction of Ru(II)K115C-gsNOS 
 Luminescence decay traces (630 nm) for the *Ru(II) excited state of our 
photosensitizer-labeled gsNOS system, Ru(II)K115C-gsNOS, are described by a 
biexponential function (!1 = 1.2 µs and !2 = 150 ns). !1 is very similar to the lifetime of 
free [Ru(bpy)2(A-phen)]2+ model complex. This biexponential behavior has been seen 
before in other labeled proteins22 and is attributed to multiple possible solution 
conformations of the ruthenium complex attached to the protein that do not interconvert 
on the timescale of the measurements. Upon introduction of MeODMA quencher, this 
luminescence decay is effectively quenched resulting in a single observed lifetime 
(!quenched = 60 ns), similar to that of the quenched model complex (Figure 3.5). Again, we 
assign this to the formation of Ru(I). The *Ru(II) excited state is the only emissive 
species in our system, so transient luminescence data alone do not report on what is 
happening at the heme center of gsNOS. 
      
Figure 3.5 Comparison of *Ru(II) luminescence decay of labeled gsNOS with and 
without quencher, excited at 480 nm and monitored at 630 nm. [Ru(II)K115C-gsNOS] = 8 
µM and [MeODMA] = 8 mM, 50 mM sodium phosphate buffer, pH 7. 
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TA measurements were performed to track changes in both the ruthenium 
photosensitizer and the gsNOS heme oxidation states. The mixed-spin ferric-aquo resting 
state of gsNOS has a Soret maximum at 403 nm that shifts to 415 nm with shoulder 
broadening at 450 nm upon reduction to the ferrous state (Figure 3.2).14 The MLCT 
bands of the [Ru(bpy)2(A-phen)]2+ label are also sensitive probes (as described in the 
previous section). In the absence of quencher, laser excitation at 480 nm results in 
formation of the *Ru(II)K115C-gsNOS-Fe(III) excited state that is characterized by a 
negative !OD in the Ru(II) absorbance with a return to baseline on the same timescale as 
its luminescence decay (Figure 3.6). We find no evidence for transient species associated 
with changes in the heme Soret absorbance. 
 
Figure 3.6 Transient absorption traces of the labeled Ru(II)K115C-gsNOS system in the 
absence of quencher showing nearly instantaneous formation of *Ru(II) and the slower 
decay back to the Ru(II) ground state. Return rates match luminescence data and are 
independent of wavelength, however the magnitude changes from 400 to 440 nm  
[Ru(II)K115C-gsNOS] = 8 µM, 50 mM sodium phosphate buffer, pH 7. 
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In contrast, TA measurements of Ru(II)K115C-gsNOS made in the presence of 
quencher are distinct from the signals arising from the unquenched system showing a 
faster loss of *Ru(II) signal and an overall increase in !OD at longer times associated 
with the formation of ferrous heme (Figure 3.7).  
            
Figure 3.7 Transient absorption data at 440 nm of  Ru(II)K115C-gsNOS in the presence 
and absence of quencher. [Ru(II)K115C-gsNOS] = 8 µM, [MeODMA] = 8 mM, 50 mM 
sodium phosphate buffer, pH 7. 
 
 
 
Heme reduction in Ru(II)K115C-gsNOS is further verified by a persistent bleach at 
400 nm and a corresponding absorbance increase at longer wavelengths (410–440 nm) 
(Figure 3.8), as expected from the red-shifted and broadened Soret band of ferrous 
gsNOS. 
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Figure 3.8 Transient absorption data of the quenched Ru(II)K115C-gsNOS system at 
various wavelengths diagnostic of changes in heme Soret. [Ru(II)K115C-gsNOS] = 8 µM 
and [MeODMA] = 8 mM, 50 mM sodium phosphate buffer, pH 7. 
 
 
The data at early times are described by a biphasic kinetics model for all 
wavelengths measured, followed by a slow return to baseline at longer timescales. The 
initial phase is assigned as formation of Ru(I)K115C-gsNOS-Fe(III) with a pseudo-first-
order rate constant of k1 = 1.7 x 107 s-1 (!1 = 60 ns) that nicely matches the single 
exponential rate of quenched model complex (k = 2.1 x 107 s-1) and the second phase as 
heme reduction to form Ru(II)K115C-gsNOS-Fe(II) with a rate of k2 = 1.6 x 106 s-1 (!2 = 
625 ns) (Figure 3.9). Global least-squares analysis of TA data from each of 400, 410, 
420, 430, and 440 nm yield the same rates. Finally, the heme is reoxidized to form the 
initial state Ru(II)K115C-gsNOS-Fe(III) with a lifetime on the order of ! ~ 500 µs. The 
reoxidation step is presumably achieved by recombination with MeODMA radical cation, 
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but we cannot rule out other pathways such as trace impurities or O2 trapped in the 
protein matrix.  
      
Figure 3.9 Biphasic kinetics of flash-quenched Ru(II)K115C-gsNOS at 440 nm in 
comparison with the model complex [Ru(bpy)2(A-phen)]2+ at fast timescales. 
[Ru(II)K115C-gsNOS] = 8 µM, [[Ru(bpy)2(A-phen)]2+] = 8 µM,  [MeODMA] = 8 mM, 50 
mM sodium phosphate buffer, pH 7. 
 
 
To summarize the previous data, the observed formation of Ru(I)K115C-gsNOS-
Fe(III) occurs on the timescale of 60 ns, which is confirmed by both the quenched 
luminescence lifetime of Ru(II)K115C-gsNOS and by the TA data for quenched model 
complex. The ferrous Ru(II)K115C-gsNOS-Fe(II) species forms with a rate of kobs = 1.6 x 
106 s-1, occurring on the order of 625 ns, which is in the range calculated from semi-
classical ET theory (see chapter two for calculations). These data show that we can 
indeed rapidly inject electrons into the heme from a surface-bound photosensitizer using 
reductive flash-quench methodology.  
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Photoreduction of Ru(II)K115C-gsNOS in the Presence of Substrate/Cofactor  
 Substrate and cofactor binding to gsNOS induce a number of changes that may 
affect the rate of heme reduction. In the NOS catalytic cycle, the binding of substrate 
(either L-Arg in the first turnover or NOHA in the second) sterically displaces the bound 
water molecule from the ferric resting state. The resulting five-coordinate high-spin ferric 
state can then be reduced by one electron from the reductase domain.5 In the previous 
section, we showed that our covalently attached ruthenium(II) diimine photosensitizer 
was capable of reducing the six-coordinate mixed-spin ferric-aquo heme resting state of 
gsNOS in reductive flash-quench experiments. In addition to the electronic environment 
of the heme active site being different in the presence of substrate, each of the substrates 
binds with different affinities. In most cases the enzyme-bound intermediate, NOHA, 
binds more tightly than L-Arg with dissociation constants of Ks,NOHA = 25 µM and Ks,L-Arg 
= 75 µM for bacterial NOS from Staphylococcus aureus (saNOS).25 This difference in 
affinity, as well as distinct substrate interaction with heme-bound dioxygen, enables 
regulation of the chemistry afforded in each of the two catalytic turnovers.2 
As well as binding the substrates L-Arg and NOHA, NOS binds the unique redox 
cofactor, H4B. This cofactor is necessary to supply the second reducing equivalent in the 
catalytic cycle.10 There is a specific H4B binding site known as the “N-terminal hook” in 
mNOS that is missing in bacterial NOS. Bacterial NOS enzymes, including gsNOS, make 
up for this with specific residue substitutions on each subunit at the dimer interface.2 The 
presence of cofactor also changes the electronic environment, shifting the heme midpoint 
reduction potential by approximately 50 mV for nNOS and iNOS26 and having effects on 
heme interactions with diatomic molecules.27 
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Flash-quench experiments were performed on Ru(II)K115C-gsNOS in the presence 
of L-Arg or NOHA substrate to determine the effects of substrate binding on gsNOS 
reduction. Luminescence decays in the presence of MeODMA quencher were virtually 
identical, indicating that initial Ru(I) formation was not affected by either substrate. 
However, the TA traces of the Ru(II)K115C-gsNOS system showed differences in the 
presence of substrates and slight differences between each L-Arg or NOHA substrate. In 
the presence of quencher, all samples showed conversion of the *Ru(II)K115C-gsNOS-
Fe(III) excited state to the Ru(I)K115C-gsNOS-Fe(III) species at the same rates, followed 
by comparable formation of the Ru(II)K115C-gsNOS-Fe(II) reduced species. However, the 
rates of heme reoxidation were noticeably altered in the presence of both L-Arg and 
NOHA, showing slower returns to baseline with the NOHA-bound species being the 
slowest (Figure 3.10).  
Experiments were also performed with H4B to evaluate the effect of binding the 
redox cofactor, and similar results were observed in TA measurements (Figure 3.11). The 
presence of H4B slows the reoxidation process as compared to Ru(II)K115C-gsNOS alone 
and to the substrate-bound forms. Additionally, measurements made with both L-Arg and 
H4B show even slower returns to baseline. 
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Figure 3.10 Transient absorption traces of the Ru(II)K115C-gsNOS system in the presence 
of substrates from the first and second catalytic turnovers. Comparison of Ru(II)K115C-
gsNOS with each of L-Arg and NOHA measured at a) 400 nm and b) at 440 nm. 
[Ru(II)K115C-gsNOS] = 8 µM, [L-Arg] = [NOHA] = 200 µM, and [MeODMA] = 8 mM, 
50 mM sodium phosphate buffer, pH 7. 
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Figure 3.11 Comparative transient absorption traces of the Ru(II)K115C-gsNOS system in 
the presence of the redox-active cofactor H4B +/- L-Arg measured at a) 400 nm and b) 
440 nm. [Ru(II)K115C-gsNOS] = 8 µM, [H4B] = 60 µM, [L-Arg] = 200 µM, and 
[MeODMA] = 8 mM, 50 mM sodium phosphate buffer, pH 7. 
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The rates of heme reoxidation are changed in the presence of each substrate and 
cofactor in the following order: L-Arg > NOHA > H4B > H4B + L-Arg (with H4B + L-Arg 
bound to Ru(II)K115C-gsNOS being the slowest), however the rates of initial heme 
reduction are unchanged. One could test whether heme reduction by Ru(I) is driving 
force optimized by either altering the reduction potentials of the photosensitizer (by 
changing the ligands or the metal) or of the heme itself. Usually it is easier to change the 
label, however substrate/cofactor binding alters the reduction potential of the heme in this 
case. This is means that we have altered the overall driving force for the Ru(II)K115C-
gsNOS system in each case of substrate-bound heme. Interestingly, the fact that heme 
reduction rates do not change suggests that our system is driving force optimized.  
If the above analysis is correct, the observed differences in heme reoxidation rates 
may still result from altered substrate-bound heme potentials, as the back reaction 
(presumably with the MeODMA radical cation) is not necessarily optimized. 
Alternatively, the presence of substrate could be blocking the interaction with the 
MeODMA radical cation. There is an observed contraction of the NOS dimer interface in 
the presence of substrate/cofactor that could hinder access to the heme by an oxidizing 
species. There are substantial overall changes in the NOS dimeric structure in the 
presence of both substrate and cofactor. Crystal structures of NOS from Bacillus subtilis 
(bsNOS) show two distinct dimer conformations in the presence and absence of 
substrate/cofactor: a “tight” and “loose” form (Figure 3.12).28 Substrate/cofactor binding 
induces formation of the “tight” dimer, resulting in structural changes at the interface that 
bring the two heme active sites closer by approximately 3 Å and translates the subunits 
by 11 Å. The buried surface area at the dimer interface condenses from 1115 to 480 Å2 
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per subunit. Furthermore, the helical T-regions lose most of their interactions in the 
“loose” form, whereas they make close contacts in the “tight” form that are crucial to 
dimer stability. The consequence of this increased peripheral rigidity and increased dimer 
association is that the heme is markedly less solvent-exposed in the presence of 
substrate/cofactor. If such a dimeric contraction is occurring with our Ru(II)K115C-gsNOS 
system, it could account for the ordering of decreased reoxidation rates. 
Figure 3.12 Ribbon diagrams of the crystal structures of bsNOS in presence and absence 
of substrate/cofactor. Subunits are shown in pink and light blue. a) bsNOS with the bound 
substrate L-Arg forms a “tight” dimer with close contacts formed by the helical T and N-
terminal hairpin from each subunit and b) bsNOS in the absence of substrate forms a 
“loose” dimer and translates one subunit by approximately 11 Å exposing 50% more 
surface area. Figure reproduced from Pant.28 
 
 
 
Photoreduction in the Presence of Oxygen  
 The previous sections described photo-triggered reduction of labeled gsNOS in 
the presence of substrates and/or cofactor. In order to access the rest of the catalytic cycle 
(see Figure 3.1), and potentially observe high-valent intermediates, dioxygen must be 
present. Once the heme is reduced, O2 binds to give the ferrous-oxy species (Fe(II)-O2). 
In wild-type gsNOS, this species is remarkably long-lived with a lifetime on the order of 
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minutes.14 Single turnover experiments have been reported: in the absence of substrate, a 
mixture of species that presumably include both Fe(II)-oxy and Fe(III) states are 
observed, as evident by a broad and flattened Soret around 413 nm. The presence of L-
Arg considerably simplifies these experiments with clean formation of gsNOS Fe(II)-O2 
with a Soret maximum at 427 nm (Figure 3.13). 
      
Figure 3.13 UV-visible absorption spectra of the ferrous-oxy complex conversion to the 
ferric species in the presence of L-Arg from stopped-flow experiments. Chemically 
reduced w.t. gsNOS loaded with substrate and injected with oxygenated buffer, spectra 
recorded every 5 sec. Figure reproduced from Sudhamsu.14  
 
 
Flash-quench experiments in the presence of oxygen have been performed for the 
model complex and the labeled enzyme, in the presence and absence of 
substrates/cofactor. It should be noted at the outset that these data were very confusing 
and further complicated by interaction of oxygen with the Ru(bpy)2(A-phen)]2+ model 
complex and/or the MeODMA radical cation. These interactions preclude any definitive 
assignment of oxygenated intermediates. Transient absorption measurements have been 
recorded for five wavelengths between 400 and 440 nm. Since the cleanest conversion to 
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Fe(II)-O2 was previously observed for L-Arg bound enzyme as monitored at 427 nm,14 
this discussion focuses predominantly on data from 430 nm traces.  
 
Photoreduction of Model Complex in Presence of Oxygen 
Flash-quench experiments of the [Ru(bpy)2(A-phen)]2+ model complex in the 
presence of oxygen have been performed in order to investigate possible oxygen 
interactions with the *Ru(II) excited state, the transiently-formed Ru(I) state, or the 
MeODMA radical cation. Aerated samples containing [Ru(bpy)2(A-phen)]2+ and 
MeODMA were excited at 480 nm and the quenched luminescence decay measured at 
630 nm. Degassed and aerated samples showed virtually identical luminescence decay 
kinetics and it was determined that formation of *Ru(II) and the subsequent formation of 
Ru(I) were unchanged by O2.  
Transient absorption traces of the same system reveal differences in the presence 
of O2. Following the same rates of Ru(I) formation, a species with a positive absorbance 
grows in on the microsecond timescale. The identity of this species is unknown, however 
it must come from an interaction between O2 and either the MeODMA radical cation or 
the transiently formed Ru(I) model complex. These types of signals were observed at all 
wavelengths measured. Representative traces are shown in Figure 3.14. Unfortunately, 
this means that any signals in the labeled-protein system arising on that timescale cannot 
be unambiguously assigned to protein-based species. 
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Figure 3.14 Transient absorption traces at 430 nm of the quenched model complex in the 
presence and absence of oxygen. [Ru(bpy)2(A-phen)]2+] = 8 µM and [MeODMA] = 8 
mM, 50 mM sodium phosphate buffer, pH 7. 
  
Photoreduction of Ru(II)K115C-gsNOS in the Presence of Oxygen  
Flash-quench experiments of the Ru(II)K115C-gsNOS system in the presence of 
oxygen have been performed in the presence and absence of substrate and cofactor. 
Under the same conditions previously used for the model complex, aerated samples 
containing Ru(II)K115C-gsNOS and MeODMA were excited at 480 nm and luminescence 
decay measured at 630 nm. These data for quenched Ru(II)K115C-gsNOS were virtually 
identical, regardless of the presence of substrate, cofactor, or oxygen. As with the model 
complex, these data indicate that formation of *Ru(II) and subsequent conversion to Ru(I) 
are unaffected by O2.  
All TA traces of substrate-bound Ru(II)K115C-gsNOS show substantial differences 
in the presence of O2, however there is no clear formation of an Fe(II)-O2 species. 
Qualitatively, it can be seen that Ru(I) forms with the same initial rate, but that the 
positive !OD associated with Fe(II) formation and the reoxidation event are altered 
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(Figure 3.15-a). Biphasic kinetics are observed in the early timescale data (Figure 3.15-b) 
and fitting yields the same Ru(I) formation rates: k1 = 1.7 x 107 s-1 (!1 = 60 ns) for both 
degassed and aerated samples. The rate constant for the second phase is different with 
k2,degas = 2.1 x 106 s-1 (!2,degas = 500 ns)  and k2,oxygen = 8.9 x 105 s-1 (!2,oxygen = 1.1 µs).      
          
Figure 3.15 Transient absorption traces at 430 nm of the quenched Ru(II)K115C-gsNOS 
system loaded with substrate +/- oxygen a) at longer timescales and b) biphasic kinetics 
of the first 10 microseconds. [Ru(II)K115C-gsNOS] = 8 µM, [L-Arg] = 200 µM, and 
[MeODMA] = 8 mM, 50 mM sodium phosphate buffer, pH 7. 
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In the degassed system, k2,degas corresponds to the rate of Fe(II) formation. In the 
samples containing oxygen, this slower second rate (k2,oxygen) for could reflect a number 
of processes. Altered Fe(II) formation, formation of a new species, or most likely, 
interaction of Ru(I) or MeODMA with O2, could give the observed rate. Simple slower 
Fe(II) formation does not seem reasonable, since whatever amount of transiently formed 
Ru(I) that is available should still inject electrons to reduce the heme at the same rate.  
Comparing the data from the model system with the labeled protein shows similar 
initial TA signals, followed by a positive !OD at longer times that could be associated 
with a transient protein-based species (Figure 3.16-a, phase 3). Examination of the data at 
early timescales (0–10 µs) reveals the same distribution of biphasic rates for both samples 
in the presence of O2: a fast rate confirmed as the formation of Ru(I) followed by a 
second rate that is slower in the aerated samples (Figure 3.16-b, phases 1 and 2). Thus, 
this altered second phase (k2,oxygen, also seen in the aerated protein system) must be 
attributed to the model complex and/or quencher and not to early formation of some other 
heme-protein species.  
Formation of a new species, specifically Fe(II)-O2, is an appealing cause for the 
altered signal in “phase 3” (Figure 3.16-a), however from the ground state UV-vis 
spectra14 we would expect to see a further increase in !OD at 430 nm as compared to the 
degassed sample. It is possible that something else is affecting the yield of the ferrous-
oxy species and could only be determined by a very careful examination of absorbance 
profiles across the full wavelength range. 
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Figure 3.16 Transient absorption traces at 430 nm comparing the substrate-loaded 
[Ru(II)K115C-gsNOS] system with the model complex in the presence of oxygen a) data at 
long timescale showing growth of protein signal from 100 µs to 1 ms, and b) the same 
data from 0 to 10 µs showing kinetics attributed to the interaction of model and/or 
quencher with oxygen. [Ru(II)K115C-gsNOS] = [Ru(bpy)2(A-phen)]2+] = 8 µM, [L-Arg] = 
200 µM, and [MeODMA] = 8 mM, 50 mM sodium phosphate buffer, pH 7. Phases are 
labeled 1–3. 
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Overall, the data from oxygenated samples of labeled gsNOS are complicated by 
the fact that the ruthenium(II) diimine label and/or the quencher radical cation are 
interacting with O2. While the transient signals arising in “phase 3” are possibly protein 
derived, we cannot definitively assign them as formation of the desired ferrous-oxy 
species. We assume that the rate of O2 binding is very fast (pseudo-first-order at these 
protein concentrations) once the ferrous state is formed. Unfortunately, we cannot 
separate the rates from the uncontrolled interactions with label/quencher and thus cannot 
yet extract this diatomic ligand-binding rate. Despite these confusing results, additional 
experiments were performed on the [Ru(II)K115C-gsNOS] system fully loaded with each 
substrate (L-Arg and NOHA) and the redox-active cofactor H4B in the presence of O2. 
These were done under the hypothesis that if enough Ru(I) was formed, regardless of 
possible interactions with oxygen, one NOS cycle could be  run and perhaps downstream 
intermediates observed. Those data (not shown) were equally complicated, with no clear 
formation of new transient species. Given the complexities of this system, full 
wavelength TA is needed to monitor changes in both shape and intensity of the Soret 
bands. 
 
3.3 Conclusion 
 The covalent attachment of a ruthenium(II) diimine photosensitizer to the surface 
of gsNOS has provided a system whereby we can rapidly phototrigger heme reduction in 
the absence of a reductase domain. Reductive flash-quench methodology using the 
organic quencher, MeODMA, results in transient absorption signals assigned to 
Ru(I)K115C-gsNOS-Fe(III), followed by formation of the Ru(II)K115C-gsNOS-Fe(II) 
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species. This ferrous species forms with a rate of kobs = 1.6 x 106 s-1 and a time constant 
(!) of 625 ns that falls nicely within the range of reduction rates calculated from semi-
classical electron transfer theory in chapter two. gsNOS heme reduction has also been 
achieved in the presence of substrates (L-Arg and NOHA) and the redox cofactor (H4B); 
the rates of Fe(II) formation are comparable, despite substrate/cofactor-induced changes 
in "G°, suggesting this system may be driving force optimized for heme reduction by 
Ru(I). Interestingly, the reoxidation rates are slower, perhaps reflecting the dimeric 
structural changes associated with substrate/cofactor binding. Further studies were carried 
out in the presence of oxygen with the hopes of running the full cycle and observing 
high-valent oxygenating intermediates. Unfortunately, the kinetics were extremely 
complicated by interactions of the redox-active O2 ligand with the ruthenium(II) diimine 
label itself and/or the MeODMA quencher radical cation. Additional studies are needed 
to explore the diatomic ligand-binding event to the ferrous enzyme and will be discussed 
in chapter five of this thesis. Since no definitive assignments of transient intermediates 
beyond the ferrous state were possible in these experiments, it was determined that the 
activity of our labeled enzyme should be tested by an independent technique. These 
experiments and data will be described in chapter four.  
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3.5 Materials and Methods 
Materials 
Labeled protein Ru(II)K115C-gsNOS was prepared as described in chapter two of 
this thesis. L-arginine (L-Arg, Sigma) was used as received and stored at room 
temperature. N!-hydroxy-L-arginine acetate salt (NOHA, Sigma) was stored at 4 °C and 
freshly dissolved before each use to prevent hydrolysis. (6R)-5,6,7,8-tetrahydrobiopterin 
(H4B, Sigma) was stored at -20 °C. The model complex [Ru(bpy)2(A-phen)]2+ was 
synthesized for a different project and was generously shared for use in these 
experiments. The synthesis followed procedures described in chapter two for the full 
label, however iodoacetic anhydride was replaced with acetic anhydride. p-methoxy-N.N-
dimethylanaline (MeODMA) was previously synthesized by a former student according 
to published procedures.29 To remove any age-related impurities, the stock of MeODMA 
was purified by sublimation under static vacuum (at ~75 °C) and portions of the white 
crystalline solid were stored in a dessicator under argon gas in between uses. Fresh stock 
solutions of the quencher MeODMA were made before each set of experiments and kept 
dark. Due to its limited solubility in water, 8 mg of MeODMA were first dissolved in 
500µL of dimethyl sulfoxide (DMSO) and brought up to a total volume of 2.5 mL by 
dropwise addition of 50 mM sodium phosphate buffer resulting in a 25 mM stock 
solution (attempts to increase the stock concentration resulted in supersaturated solutions 
and precipitation).  
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General Sample Preparation 
All samples were prepared in 50 mM sodium phosphate (NaPi) buffer, pH 7 using 
Milli-Q (18.2 M!) water and filtered (0.22 µm, Millipore) before use. Note: all 
ruthenium(II) diimine-containing samples were kept covered in foil or handled under red 
light to prevent photodamage. Specialized 1 cm pathlength quartz cuvettes (Starna Cells) 
fitted with Kontes valves and side-arm ground-glass Schlenk adaptors were made in-
house at the Caltech glassblowing shop (Rick Gerhart). Cuvettes containing micro stir 
bars were attached to a Schlenk line and degassed by three sets of ten pump-purge cycles 
(very quick vacuum, followed by argon back-filling) spaced in 15 min intervals. This 
method provides a gentle way to degas protein samples that avoids denaturation caused 
by bubbling. Argon gas was precleaned by a commercially available oxygen scrubber 
before entering the line (Oxiclear, Labclear). 
Typical sample volumes were 2 mL to provide enough height in the cuvette to 
accommodate both a micro stir bar and the width of laser/probe light without spatial 
interference. Labeled protein and model complex concentrations were chosen to balance 
decent signal size with ground state absorbance in the range of 0.8 OD at the Soret 
maximum and 0.4 at the Ru shoulder. Quencher concentrations were kept at 1000-fold 
excess to allow fitting of pseudo first-order kinetics. Substrate and cofactor 
concentrations were chosen to ensure all proteins were bound and mimicked conditions 
used in published single-turnover studies. Sample component concentrations were as 
follows: [Ru(II)K115C-gsNOS] = 8 µM, [[Ru(bpy)2(A-phen)]2+] = 8 µM, [MeODMA] = 8 
mM, [L-Arg] = 200 µM, [NOHA] = 200 µM, [H4B] = 60 µM. UV-visible absorption 
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spectra were collected for all samples before and after laser experiments to confirm 
concentrations and to monitor sample stability. 
 
Spectroscopic Measurements 
All steady state and time-resolved spectroscopic measurements were carried out at 
the Beckman Institute Laser Resource Center. UV-visible absorption spectra were 
recorded on an Agilent 8453 UV-vis Spectrophotometer. Laser excitation for time-
resolved measurements was provided by 8 ns pulses from a 10 Hz Q-switched Nd:YAG 
laser (Spectra-Physics Quanta-Ray PRO-Series). The third harmonic (355 nm) was used 
to pump an optical parametric oscillator (OPO, Spectra-Physics Quanta-Ray MOPO-700, 
tunable in the visible region). Laser light from the OPO at 480 nm with a final power of 
approximately 10 mJ/pulse (at the sample) was used to excite samples. Schematic for 
transient luminescence measurements is shown in Figure 3.17. 
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Figure 3.17 Laser and optical configuration used in transient luminescence studies. 
Following laser excitation, the light emitted from the sample is focused into the 
monocromator to select a specific wavelength and then collected at the PMT allowing for 
time-resolved measurements at a single wavelength. PD = photodiode used for timing 
shutter control, ND = neutral density filter, and i = iris used for alignment. All other 
components are described in the text. Note that the configuration is the same for transient 
absorption measurements minus the probe light source (see Figure 3.18). 
 
 
 
Probe light for transient absorption kinetics measurements was provided by a 75 
W arc lamp (PTI Model A 1010) that can be operated in continuous wave or pulsed 
modes. Timing between the laser and the probe light was controlled by a digital delay 
generator (EG&G 9650). After passing through the sample collinearly with the laser 
beam, probe wavelengths were selected for detection by a double monochromator 
(Instruments SA DH- 10) with 1 mm slits. Transmitted light was detected with a 
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photomultiplier tube (PMT, Hamamatsu R928) (Figure 3.18). The PMT current was 
amplified and recorded with a transient digitizer (LeCroy 9354A or Tektronix DSA 602). 
The data were converted to units of !OD (!OD = -log10(I/I0), where I is the time-resolved 
probe-light intensity with laser excitation, and I0 is the intensity without excitation).  
Samples measured on the microsecond timescale or faster were stirred 
continuously and excited using a laser repetition rate of 10 Hz, with 100 shots/cycle x 3 
cycles. Samples measured on a millisecond timescale were excited with a shutter-released 
laser pulse, stirred for 1 sec after collecting data, then allowed to sit for 2 sec until the 
solution settled before the next laser pulse. The sample was shot 1/cycle x 20 cycles in 
this configuration. All instruments and electronics in these systems were controlled by 
software written in LabVIEW (National Instruments). 
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Figure 3.18 Optical configuration for transient absorption measurements. The arc lamp 
provides probe light through the sample along the same path as laser excitation. Initial 
probe light is collected through the ground state sample providing a blank measurement. 
Laser pulses are then timed to excite the sample and the resulting light transmitted 
through the excited state of the sample is recorded at the PMT. Laser source and 
component abbreviations are as in Figure 3.17 for the transient luminescence setup. 
 
Data Fitting 
 Initial transient absorption data manipulation was performed using MATLAB 
R2010a (Mathworks, Inc.) as follows: for each wavelength, data from three different 
timescales (2 µs, 100 µs, and 100 ms) were logarithmically compressed with 600 points 
per decade. The compressed data were adjusted to match intensities by inspection, spliced 
together, and the x-axis was shifted to set the signal rise to t = 0. Data were fit to multiple 
exponentials using nonlinear least-squares minimization and quality of fit was evaluated 
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by inspection of residuals. Global least-squares analysis was used to fit data from 
multiple wavelengths to a single set of rates and amplitudes. Plots were made using 
IgorPro 6.1 (Wavemetrics). 
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4.1 Introduction 
 Nitric oxide synthase (NOS) is a monooxygenase responsible for the biological 
production of the radical nitric oxide (NO).1 NOS converts the amino acid L-arginine (L-
Arg) to L-citrulline (L-Cit) and NO via a stable enzyme-bound intermediate, N!-hydroxy-
L-arginine (NOHA).2 This reaction proceeds in two turnovers of the catalytic cycle. There 
are three NOS isoforms found in mammals (mNOS)3 and NOS-like enzymes have now 
been discovered in all kingdoms of life, including archaea and bacteria.4 All NOS 
isoforms function as homodimers and share nearly identical active sites containing a 
cysteine-ligated heme, as well as substrate and redox cofactor binding sites. However 
there are some differences between mNOS and bacterial NOS. The most striking 
difference is that while mNOSs have a linked reductase domain,5 all but one of the 
bacterial NOS enzymes lack a dedicated reductase domain.6 Chapter one of this thesis 
provides details about the domains of mNOS and structural differences in bacterial NOS. 
 The full mechanism by which NOS catalytically produces NO from L-Arg is still 
unknown,3 however steps can be borrowed from other members of the cysteine thiolate-
ligated heme enzyme superfamily to which it belongs. The first NOS turnover is a two-
electron oxidation of L-Arg resulting in the hydroxylation of a guanidinium nitrogen in a 
reaction that is nearly identical to that of cytochrome P450-catalyzed hydroxylation; the 
second turnover, a three-electron oxidation to form NO and L-Cit, is thought to follow a 
unique mechanism.7 The NOS resting state is a six-coordinate mixed-spin aquo-ferric 
heme. Substrate binding (L-Arg in the first cycle and NOHA in the second) in the pocket 
sterically displaces water to form a five-coordinate high-spin ferric state. Ferric NOS is 
reduced by one electron originating from the reductase domain to give a ferrous species 
! "#!
that can bind O2. This ferrous-oxy species (often represented as a ferric-superoxide) is 
further reduced by one electron supplied by the redox-active cofactor (6R)-5,6,7,8-
tetrahydrobiopterin (H4B, pterin).8 To date, the next experimentally observed species is 
the ferric resting state with bound NOHA. The second turnover shares similar steps: 
reduction, O2 binding, and reduction by H4B. From there, the next observed species is the 
NO-bound ferric heme, which then releases NO and L-Cit to complete the cycle. The 
missing oxygenating intermediates are thought to be a ferryl porphyrin radical cation9 
(analogous to Cpd I in P450) in the first turnover and either a hydroperoxo ferriheme10 or 
Cpd I formed by subsequent protonation/water loss in the second9 (Figure 4.1). 
 
Figure 4.1 Putative mechanism for the catalytic production of NO by NOS enzymes: (1) 
first turnover formation of NOHA from L-Arg, shown in blue path; (2) second turnover 
formation of L-Cit and NO radical from NOHA, shown in orange path. The proposed 
oxygenating intermediates are shown in brackets. 
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 Flash-quench methodology11 has been developed in the Gray group to gain access 
to short-lived intermediates and is described more thoroughly in chapters one and three of 
this thesis. Briefly,  laser excitation (the “flash”) into the metal-ligand charge-transfer 
(MLCT) band of a ruthenium(II)diimine photosensitizer (e.g., [Ru(bpy)3]2+, bpy = 2,2’-
bipyridine) creates an electronic excited state approximately 1.2 eV above the ground. 
This excited state can be “quenched” by an appropriate small molecule in solution 
yielding either a powerful -1.3 V reductant or +1.3 V oxidant12 that can then go on to 
inject or pull electrons from the system of interest, such as heme. High-valent 
intermediates from various heme-containing proteins have been photoinduced using these 
techniques and these species have been observed by transient absorption (TA) 
spectroscopy.13–15  
With the motivation of catching high-valent intermediates in the NOS catalytic 
cycle, a ruthenium(II) diimine photosensitizer has been covalently attached to the surface 
of NOS from the thermostable, nonpathogenic bacterium Geobacillus stearothermophilus 
(gsNOS). As gsNOS, like most bacterial NOS enzymes, lacks a dedicated reductase 
domain, we have the opportunity to supply electrons to the active site via a 
photosensitizer, thus side-stepping the need for a reductase domain entirely. A single 
surface cysteine mutation has been installed at position 115 in gsNOS for selective 
labeling with [Ru(bpy)2(IA-phen)]2+ (where IA-phen = 5-iodoacetamido-1,10-
phenanthroline). The resultant conjugate, Ru(II)K115C-gsNOS, has been characterized and 
crystallized with the structure solved to a resolution of 2.6 Å. Details regarding the 
expression, labeling, and full characterization can be found in chapter two of this thesis. 
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 Reductive flash-quench experiments with this labeled Ru(II)K115C-gsNOS system 
have been performed and are described in chapter three of this thesis. Anaerobic samples 
containing Ru(II)K115C-gsNOS and an excess of the small-molecule quencher, p-methoxy-
N.N-dimethylanaline (MeODMA) were irradiated with pulsed laser light at 480 nm (the 
“flash”) to form the *Ru(II) excited state as outlined in Scheme 4.1 below.  
              
Scheme 4.1 Reductive flash-quench scheme for heme reduction in gsNOS. Ru represents 
the [Ru(bpy)2(IA-phen)]2+ complex attached to gsNOS, Q represents the quencher 
MeODMA, and Fe represents gsNOS heme. 
 
Following laser excitation, the *Ru(II)K115C-gsNOS-Fe(III) excited state is quenched by 
MeODMA to transiently form Ru(I)K115C-gsNOS-Fe(III). This Ru(I) species can then 
rapidly reduce the ferric resting sate of the gsNOS heme to form the ferrous enzyme 
Ru(II)K115C-gsNOS-Fe(II). Presumably, recombination with the MeODMA radical 
cation16 reoxidizes the heme to form the initial Ru(II)K115C-gsNOS-Fe(III) state. Both the 
MLCT bands of the ruthenium complex and the Soret bands of the heme are sensitive to 
changes in oxidation state17 and these absorption features can thus be used as 
spectroscopic handles to follow these types of processes. As such, transient absorption 
(TA) spectroscopy was performed and signals measured at various wavelengths in the 
range of 400–440 nm. The data from these experiments clearly show successful and rapid 
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electron injection into the heme from a surface-bound photosensitizer using reductive 
flash-quench methodology. The measured rate of electron transfer (ET) for this system is 
kobs = 1.6 x 106 s-1, with ferrous formation on the order of 625 ns. 
Since the original goal was to observe the NOS catalytic cycle in action, similar 
flash-quench experiments were conducted with substrate- and cofactor-loaded enzyme in 
the presence of oxygen. In these experiments, flash-quench should produce a ferrous 
heme that readily binds O2 to form the Fe(II)-oxy species and thus begin the catalytic 
cycle (Figure 4.1). Unfortunately, the kinetics were drastically complicated by 
interactions of O2 with the transiently formed Ru(I) state of the label and/or the 
MeODMA quencher radical cation. While certain changes in the TA signals were 
suggestive of formation of a new species, definitive assignment of Fe(II)-oxy was not 
possible. It was determined that the light-driven activity of our ruthenium-modified 
enzyme should be tested by independent techniques (all of the laser experimental details 
and kinetics analyses can be found in chapter three). 
 Recently, a number of exciting examples of light-driven catalysis have been 
reported which have inspired the work described in this chapter. Nitrogenase catalyzes 
the biological reduction of nitrogen (N2) to form ammonia (NH3). This ATP-dependent, 
eight electron/eight proton reaction is achieved by cooperativity between two domains. 
Hydrolysis of two ATP molecules by the iron-protein (FeP) allows for injection of one 
electron at a time to the iron-molybdenum protein (MoFeP) that houses the active site. 
Characterization of reaction intermediates has been complicated by this continuous flow 
of electrons. A system has been designed that decouples this reaction by labeling the 
MoFeP active-site component with a ruthenium photosenzitizer and thus bypasses the 
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need for the FeP reductase protein.18 In these experiments, they were able to show light-
driven six-electron catalytic reduction of hydrogen cyanide to form methane and 
ammonia as detected by gas chromatography mass spectrometry (GC-MS).  
 Two more examples come from systems involving cytochromes P450 (CYP) 
where the required first reduction step is achieved by external light-driven “reductases.” 
These studies are of particular interest as the first turnover of NOS is thought to follow 
similar steps to the catalytic cycle of P450 (refer to Figure 4.1). It was recently 
demonstrated that an engineered in vitro system using isolated photosystem I (PSI) and 
isolated membrane-bound P450 can carry out hydroxylation chemistry.19 In these 
experiments, PSI provides light-driven electron transport through a ferredoxin mediator 
to CYP79A1, which catalyzes the transformation of L-tyrosine to (E/Z)-p-
hydroxyphenylacetaldoxime. In another example, a ruthenium-modified P450-BM3 
system was shown to selectively hydroxylate lauric acid under steady illumination with 
visible light.20 Reductive flash-quench conditions were used to drive the necessary heme 
reduction to initiate catalysis in the presence of substrate, O2, and the sacrificial quencher 
sodium diethyldithiocarbamate (DTC) (Scheme 4.2). Product formation was monitored 
by gas chromatography following derivatization of the functional groups. 
 
Scheme 4.2 Proposed photocatalytic cycle for ruthenium-modified P450-BM3 enzymatic 
hydroxylation of lauric acid. Scheme reproduced from Tran.20 
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enzymes were further purified using an anion exchange column
(Fig. S1w). The purified hybrid enzymes were characterized by
UV-vis and fluorescence spectroscopic techniques as well as
mass spectrometry (Fig. S2–S4w).
Upon light excitation into the metal-to-ligand charge transfer
(3MLCT) absorption band, the long-lived Ru(II) excited state
can be quenched in situ by a sacrificial electron donor to create a
highly reductive Ru(I) species with an E0 = !1.26 V vs.
NHE.14,18 This reductant generated via bimolecular reductive
flash quench technique has been used to reduce various active
site and model complexes.19 Among several sacrificial reductive
quenchers investigated, sodium diethyldithiocarba ate (DTC)
fulfills the desired requirements. It is an irreversible sacrificial
electron donor, inexpensive, highly water soluble and capable of
quenching the Ru(II)* emission (Fig. S4w).18b,19a Following the
photocatalytic cycle highlighted in Scheme 1, we investigated
the ability of the hybrid nzymes to catalyze the hydroxylati n
of lauric acid under constant visible light irradiation.
Typically, the activity of the hybrid enzymes was determined
as follows: an aerated solution of the hybrid enzyme (3 mM), in
the presence of excess lauric acid (1.5 mM) and DTC
(100 M), was continually irradiated with visibl light. The
formation of hydroxylated products was monitored by gas
chromatography after extraction of the reaction mixture and
derivatization of the acid and alcohol groups.6 The peroxygenase
activity of the wild type heme domain (BM3-WT) u der the
peroxide shunt was used as a co trol reaction. Using 10 mM
H2O2, the BM3-WT heme domain is rapidly deactivated and
leads to only a few total turnovers (Table 1, entry 1).6a
Under the photoreductive conditions, the activity of the
hybrid enzymes, Ru-Q397C-BM3 and Ru-K97C-BM3,
exceeded the activity of the wild type using the peroxide shunt
(Fig. 2). The typical product ratio is maintained between the
BM3-WT and the hybrid enzymes, reflecting no detrimental
interactions of the label with the enzyme active site. The
hybrid enzymes require four components to be present in
order to carry out the reaction: (1) the Ru(II) photosensitizer
covalently attached to the heme domain; (2) reductive quencher
(DTC); (3) visible light excitation and (4) dioxygen as the source
of oxygen atom. In the absence of one or more components,
very low or no activity of the enzyme is detected. For example,
the use of Ru(bpy)3
2+ in solution with BM3-WT in a 1 : 1 and
10 : 1 ratio and 100 mM DTC resulted in TON similar to the
peroxide shunt (Table 1, entry 5). In the absence of DTC or
visible light, the hybrid enzymes are unable to catalyze
the hydroxylation of lauric acid (Table 1, entries 7 and 8).
Moreover, no products were detected when DTC alone was used
with BM3-WT under visible light excitation (Table 1, entry 3).
Unlike sodium dithionite (E0 = !850 mV vs. Ag/AgCl),8c DTC
(E0 = !600 mV vs. Ag/AgCl)20 does not reduce the heme
domain and is not able to sustain catalytic activity.
Fig. 1 Hybrid P450 BM3 enzymes composed of a [Ru(bpy)2-
(5-CH2CONHPhen]
2+ photosensitizer covalently attached to non-
native single cysteine residues of P450 BM3 heme domain mutants
in order to carry out the selective hydroxylation of lauric acid under
visible light irradiation and in the presence of a sacrificial electron
donor, sodium diethyldithiocarbamate (DTC).
Scheme 1 Proposed photo atalytic cycle using hybrid P450 BM3
enzymes under flash quench reductive conditions.
Table 1 Control and reaction conditions for the Ru-Q397C-BM3 and
Ru-K97C-BM3 hybrid enzymes and BM3-WT with their respective
total turnover numbers (TON)
Entry 10 mM H2O2 100 mM DTC Light TON
1 WT + ! ! o2
2 ! + ! n.d.
3 ! + + n.d.
4 WT/Ru(bpy)3
2+ ! ! + n.d.
5 ! + + o3
6 Ru-K97C-BM3/
Ru-Q397C-BM3
+ ! ! o4
7 ! + ! n.d.
8 ! ! + n.d.
9 ! + + 30/40
60/80a
a In the presence of 10 mM catalase; n.d.: not determined because
product concentration below detection limit.
Fig. 2 Representative chromatograms of trimethylsilylated derivatized
hydroxylated products (o1, o2, o3) from reactions of 3 mM BM3
enzymes with 1.5 mM lauric acid for 2 h. 12-Hydroxydodecanoic acid
was used as internal standard (I.S., 10 nmol).
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We have successfully bypassed the need for a reductase domain and achieved 
phototriggered heme reduction of Ru(II)K115C-gsNOS in the presence of each substrate 
and cofactor under reductive flash-quench conditions (chapter three). Inspired by the 
previously summarized studies of light-driven catalysis and with the desire to test the full 
enzymatic efficacy of our ruthenium-modified gsNOS system, experiments were 
designed to drive the catalytic NOS cycle using steady-state illumination with visible 
light. Since the biological products of this reaction are NO and L-citrulline, different 
detection assays are needed. The experimental setup, detection methods, and results are 
described in this chapter. 
 
4.2 Results and Discussion 
Photocatalytic Cycle of Ru(II)K115C-gsNOS  
 In order to confirm enzymatic activity of the ruthenium-modified gsNOS system 
(Ru(II)K115C-gsNOS) reductive flash-quench experiments were performed under steady-
state illumination (Scheme 4.3). Blue light (470 nm) from a light emitting diode (LED) 
was used to excite the [Ru(bpy)2(IA-phen)]2+ label. The irreversible and water-soluble 
quencher, sodium diethyldithiocarbamate (DTC), was used as a sacrificial electron donor 
to reduce the excited state of the ruthenium label. This Ru(I) species can then inject 
electrons into the heme of the gsNOS active site and hopefully initiate catalysis in the 
presence of O2, substrate and the redox-active cofactor, H4B. The full cycle begins with 
L-Arg, however NO and L-Cit can be produced starting with the native intermediate, 
NOHA. Reactions with both substrates were investigated, as the frequency of electron 
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transfer under these conditions may not be enough to get around the cycle twice starting 
with L-Arg. 
 
Scheme 4.3 Proposed photocatalytic cycle for light-driven gsNOS catalysis. Ru 
represents [Ru(bpy)2(IA-phen)]2+ attached to gsNOS, Fe represents the heme active site 
of gsNOS. 
 
Detection of Photocatalytic Production of NO (by Griess Assay) 
 The biological products of the NOS cycle are NO and L-Cit. There are a few 
different options for the detection of NO, including NO-sensitive electrodes21 and NO-
specific fluorescent probes.22 However NO reacts quickly in oxygenated water to form 
other NOx species, namely nitrate (NO3-) and nitrite (NO2-). The colorimetric Griess 
Assay (Cayman Chemicals) provides a convenient way to quantify the sum of these NO 
metabolites in vitro which are proportional to the amount of NO originally present in 
solution. The assay is based on reaction of NO2- with Griess reagents to form a highly 
colored azo dye product (Scheme 4.4).23  
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Scheme 4.4 Griess Assay reactions for the colorimetric detection of nitrites in solution. 
The final product is bright pink with a maximum absorbance at 540–550 nm. 
  
Calibration curves were made for each set of experiments by reacting known 
amounts of NO3- and NO2- standards with Griess reagents and plotting the resulting 
absorbance at 550 nm (or 540 nm) as a function of combined NO3- and NO2- 
concentration. The absorbance spectra and calibration curve for a typical set of 
experiments are shown below (Figures 4.2 and 4.3) 
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Figure 4.2 Absorbance spectra for nitrate and nitrite standards used in Griess Assay. 
There is a slight absorbance for the 0 µM nitrate standard solution that may come from 
trace amounts of nitrates in the buffer or nitrate reductase enzyme solution supplied with 
the kit. 
 
 
Figure 4.3 Calibration curve for nitrate and nitrite standards used in Griess Assay. 
Absorbance at 550 nm was determined to be more suitable for samples containing the full 
reaction mixture to avoid any residual protein absorbance. Comparative curves made with 
absorbance at 540 nm showed identical slopes. 
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The total concentration of NOx from unknown samples can then be calculated from the 
following equation: 
%NO3- + NO2-]  = 
! 
(A550 " y int )
slope
# 
$ 
% 
& 
' 
( (dilution) !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!&'()!*+",!
!
In a typical experiment, an aerated solution of Ru(II)K115C-gsNOS in sodium 
phosphate buffer, pH 7 was loaded with substrate (either L-Arg or NOHA) and the H4B 
cofactor, combined with the DTC quencher, and irradiated with 470 nm light from an 
LED. After the irradiation period, the reaction is incubated with nitrate reductase to 
convert NO3- to NO2- and ensure that all produced NOx species are accounted for,24 
before reaction with Griess reagents. The addition of Griess Reagents to the reaction 
mixture results in protein denaturation, and samples were centrifuged to remove any 
precipitated material before being carefully transferred to a cuvette for absorbance 
measurements. Representative spectra comparing the Griess products of a light-driven 
reaction using the intermediate NOHA as substrate with a dark control are shown in 
Figure 4.4. Calculations from the associated calibration curve give [NO2-] = [NO] ~ 30 
µM in the final reaction mixture.  
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Figure 4.4 Typical raw absorbance spectra for Griess Assay comparing results for the 
photo-reaction of our labeled Ru(II)K115C-gsNOS system and the dark control. Nitrate 
standards shown in gray. [Ru(II)K115C-gsNOS] = 10 µM, [NOHA] = 200 µM, [H4B] = 60 
µM, [DTC] = 200 µM, in 50 mM phosphate buffer, pH 7. Reaction was illuminated at 
470 nm for 30 min. 
 
The same experiments were performed with L-Arg as the substrate, however the 
amount of NO produced (as measured from NO2- concentration) was markedly lower. 
Given the relatively large concentration of starting L-Arg compared to the amount of the 
NOHA intermediate formed in a single turnover, it is possible that another molecule of L-
Arg simply rebinds before a second electron can be injected to finish the cycle. In such a 
scenario, very little NOx would be produced. In an effort to give the enzyme enough time 
or electrons to get around the cycle twice, illumination was increased to 4.5 and 10.5 
hours. In all cases, side-by-side comparisons of data from the Griess Assay showed 
approximately 5–6 times more NO produced from NOHA vs. L-Arg as substrate. While 
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reactions with L-Arg as substrate produced substantially less NOx than with NOHA, the 
fact that increasing reaction time lead to any increased product was encouraging.  
To explore the extent of catalytic activity, various time-course experiments were 
conducted with the fully loaded Ru(II)K115C-gsNOS system using NOHA as substrate 
(NOHA was used in these experiments as it gave the most consistent signals cf L-Arg). 
Reactions were set up in parallel under identical conditions (to the best of my pippeting 
ability) and illuminated for various times between 15 min and 10 hr. Data from 15 min 
through 4 hr 30 min as well as a dark control are shown in Figure 4.5. Data from samples 
illuminated for longer times was omitted from the graph as further dilutions were 
necessary to maintain OD < 1; these data are represented in the time plot in Figure 4.6. 
Production of NO (as measured from NO2- concentration) leveled off at 7 hrs with [NO2-] 
~ 150 µM. The initial conditions were 10 µM enzyme with 200 µM NOHA and 200 µM 
DTC, meaning that up to 15 turnovers have been achieved per enzyme using this light-
driven scheme. This leveling off could be due to running out of NOHA substrate or the 
irreversible DTC quencher. Precipitation of the NOS enzyme upon photodamage is also a 
likely problem. UV-visible absorption spectra were recorded of the longer timescale 
reactions before addition of Griess reagents (and thus before full protein denaturation) 
that showed appreciable amounts of heme Soret along with baseline scatter indicative that 
some amount of enzyme had precipitated by this point (not shown).  
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Figure 4.5 Raw absorbance data from Griess Assay of the photoreaction of Ru(II)K115C-
gsNOS system at different illumination times between 15 min and 4.5 hr. Nitrate 
standards are shown in gray. [Ru(II)K115C-gsNOS] = 10 µM, [NOHA] = 200 µM, [H4B] = 
60 µM, [DTC] = 200 µM, in 50 mM phosphate buffer, pH 7.  
 
 
Figure 4.6 Plot of nitrite concentration vs. time as measured from absorbance at 550 nm 
from Griess Assay. NO production seems to level off at approximately 7 hr reflecting 
either exhausted supply of substrate or enzyme degradation. Raw data and reaction 
conditions are given in Figure 4.5. These measurements were made in duplicate. 
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Controls 
Various control reactions were performed in addition to the dark measurements 
shown in the previous data. As expected, the removal of substrate results in no 
appreciable formation of NO (signals in the range of 0 µM nitrate standard). Removal of 
either DTC or H4B or both yields interesting results. These controls investigate the role of 
reducing equivalents: DTC is needed to quench the *Ru(II) excited state and form the 
Ru(I) responsible for injecting electrons into the heme active site of our labeled gsNOS 
system (Scheme 4.3), and H4B is needed to supply the second electron in the biological 
catalytic cycle. It was initially expected that removal of these components would shut 
down the cycle, however the data show only reduced NO production (approximately a 
third of NO produced from the fully loaded system). Given the steady-state illumination 
conditions, it is possible that *Ru(II) itself is supplying the electrons or that another NOx-
producing mechanism is at work. The triplet excited state of ruthenium(II) diimine 
complexes can be quenched by oxygen to form reactive oxygen species (ROS).25 
Quenching by energy transfer processes results in formation of singlet oxygen and by 
electron transfer results in superoxide. ROS in solution could interact with the O-H bonds 
in NOHA via radical reactions to produce variable amounts of NOx and thus give positive 
signals in the Griess Assay. Another possibility comes from minor formation of peroxide. 
In the P450 and NOS cycles, it has been proposed that hydrogen peroxide can replace the 
chemically similar two-electron reduced molecular oxygen to access the hydroperoxo 
ferriheme intermediate via a so-called “peroxide shunt.”26–28 Control reactions with 
unlabeled gsNOS loaded with NOHA, plus the [Ru(bpy)2(A-phen)]2+ model complex in 
solution, show similar amounts of NO production (regardless of DTC or H4B). However, 
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controls with unlabeled protein loaded with NOHA, H4B, and DTC (without any 
ruthenium complexes) show negligible Griess signals, as do the same samples free of 
substrate. These controls support the idea that it is the presence of the [Ru(bpy)2(A-
phen)]2+ complex (either attached to the protein, or free in solution) that creates the 
background signals associated with transformation of NOHA to NOx possibly via some 
sort of ROS reaction. To summarize, only the removal of [Ru(bpy)2(A-phen)]2+, 
substrate, or light results in complete shutdown of NOx production. Representative 
control data are compiled in Table 4.1 
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Table 4.1 Representative data from photoreaction controls. [NOx] was measured from 
Griess Assay as previously described. All samples (except dark control) were illuminated 
for 45 minutes. Note that [NOx]  = 1 µM (+/-1) comes from signals in the range of the 0 
µM nitrate standard and is considered negligible. Each measurement was made in 
triplicate. 
 
System [NOx]/µM System [NOx]/µM 
RuNOS 
+ DTC 
+ H4B 
+ NOHA 
+ Light 
 
 
30 (+/- 4) 
gsNOS + Ru Model 
+ DTC 
+ H4B 
+ NOHA 
+ Light 
 
 
8 (+/- 2) 
RuNOS 
- DTC 
+ H4B 
+ NOHA 
+ Light 
 
 
8 (+/- 2) 
gsNOS + Ru Model 
- DTC 
+ H4B 
+ NOHA 
+ Light 
 
 
8 (+/- 2) 
RuNOS 
+ DTC 
- H4B 
+ NOHA 
+ Light 
 
 
15 (+/-3) 
gsNOS + Ru Model 
- DTC 
- H4B 
+ NOHA 
+ Light 
 
 
8 (+/- 2) 
RuNOS 
- DTC 
- H4B 
+ NOHA 
+ Light 
 
 
8 (+/- 2) 
gsNOS + Ru Model 
+ DTC 
+ H4B 
- NOHA 
+ Light 
 
 
1 (+/- 1) 
RuNOS 
+ DTC 
+ H4B 
- NOHA 
+ Light 
 
 
1 (+/- 1) 
gsNOS  
+ DTC 
+ H4B 
+ NOHA 
+ Light 
 
 
1 (+/- 1) 
RuNOS 
+ DTC 
+ H4B 
+ NOHA 
- Light 
 
 
1 (+/- 1) 
Ru Model 
+ DTC 
+ H4B 
+ NOHA 
+ Light 
 
 
 3  (+/- 1) 
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Inhibitors 
 The ability of our labeled Ru(II)K115C-gsNOS system to produce NO in the 
presence of various inhibitors and substrate analogs was explored. As discussed in the 
previous section, control experiments with illuminated samples containing NOHA and 
the [Ru(bpy)2(A-phen)]2+ complex (either free in solution or bound to gsNOS), but in the 
absence of quencher and redox-active cofactor, still showed some amount of NOx 
production. These NOx species could be produced through noncatalytic routes activated 
by ROS formation. One way to help verify that NO specifically is being produced in the 
fully loaded system is to introduce an inhibitor. If the Griess signals are all simply the 
result of NOx formed from ROS interactions with NOHA in solution, then addition of an 
inhibitor should have no effect. If the amount decreases, then that suggests gsNOS 
catalyzed NO formation. 
 Recent work with NOS from Bacillus subtilis (bsNOS) compared binding 
interactions of a number of substrates and inhibitors.29 Additionally, they investigated the 
ability of bsNOS to catalyze the oxidation of L-Arg by H2O2 in the presence of these 
substrate analogs. Their data showed reasonable binding affinities for N!-methyl-L-
arginine (Me-L-Arg, ks,app = 5.3 µM) and N
!-nitro-L-arginine (NO2-L-Arg, ks,app = 0.5 
µM) as compared to L-Arg (ks,app = 5.0 µM). These values of ks,app are apparent 
dissociation constants and were calculated from difference spectra in competitive binding 
studies with imidazole. Furthermore, the presence of either Me-L-Arg or NO2-L-Arg lead 
to 95% inhibition of L-Cit formation in the H2O2 oxidation of L-Arg. As such, Me-L-Arg 
or NO2-L-Arg were chosen as good initial substrate-analogs for our studies of light-driven 
catalysis with Ru(II)K115C-gsNOS (Figure 4.7). 
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Figure 4.7 Structures of the natural NOS substrates and product compared with two L-
Arg substrate analogs. 
 
 Experiments were performed as previously outlined, except with the addition of 
either Me-L-Arg or NO2-L-Arg. A typical sample contained an aerated solution of 
Ru(II)K115C-gsNOS in sodium phosphate buffer, pH 7 that was first loaded with substrate 
(NOHA) to ensure initial binding. The H4B cofactor and DTC quencher were added, 
followed by addition of the substrate analog (Me-L-Arg or NO2-L-Arg) in a 1:1 ratio of 
NOHA:inhibitor. The samples were irradiated with 470 nm light from an LED. The 
Griess Assay was then performed as described above. Additional controls were 
performed in the absence of NOHA, as well as in the absence of protein/ruthenium 
complex (to ensure that the NO2 group of NO2-L-Arg did not provide any interference 
with the Griess Assay). The results are summarized in Table 4.2 
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Table 4.2 Representative data from Ru(II)K115C-gsNOS photoreaction in the presence of 
inhibitors/substrate-analogs. [NOx] was measured from Griess Assay as previously 
described. All samples were illuminated for 45 minutes. Note that [NOx]  = 1 µM (+/-1) 
comes from signals in the range of the 0 µM nitrate standard and is considered negligible, 
N/D = not detectable. Measurements were made in triplicate. 
   
System [NOx]/µM System [NOx]/µM 
RuNOS 
+ DTC 
+ H4B 
+ NOHA 
- Inhibitor 
+ Light 
 
 
30 (+/- 4) 
  
 
 
RuNOS 
+ DTC 
+ H4B 
+ NOHA 
+ NO2-L-Arg 
+ Light 
 
 
16 (+/- 2) 
RuNOS 
+ DTC 
+ H4B 
+ NOHA 
+ Me-L-Arg 
+ Light 
 
 
16 (+/- 3) 
RuNOS 
+ DTC 
+ H4B 
- NOHA 
+ NO2-L-Arg 
+ Light 
 
 
7 (+/- 2) 
RuNOS 
+ DTC 
+ H4B 
- NOHA 
+ Me-L-Arg 
+ Light 
 
 
5 (+/- 2) 
- RuNOS 
+ DTC 
+ H4B 
- NOHA 
+ NO2-L-Arg 
+ Light 
 
 
1 (+/- 1) 
- RuNOS 
+ DTC 
+ H4B 
- NOHA 
+ Me-L-Arg 
+ Light 
 
 
N/D 
    
 These data show that the photo-reaction of Ru(II)K115C-gsNOS to produce NO 
from NOHA (as measured from NOx) is substantially inhibited by the presence of Me-L-
Arg or NO2-L-Arg (by approximately 50%). This suggests that at a significant portion of 
the NOx detected in the system fully loaded with NOHA is in fact coming from light-
driven gsNOS catalysis. 
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Detection of Photocatalytic Production of L-citrulline (by LC-MS) 
 In order to corroborate the evidence from the Griess Assay that our ruthenium 
labeled gsNOS system is capable of light-driven catalysis, the reaction was analyzed for 
production of L-Cit using on-line liquid chromatography–mass spectrometry (LC–MS) 
and liquid chromatography tandem mass spectrometry (LC–MS–MS). Proteins can clog 
the LC columns and were thus excluded from the standard mixtures as well as filtered out 
from the actual photoreactions before application. Individual components were analyzed 
to acquire their retention times and electrospray ionization (ESI) mass spectra which are 
summarized in Table 4.3. Standard mixtures of all the reaction components (minus 
Ru(II)K115C-gsNOS) were analyzed (Figure 4.8) to gauge conditions best suited for 
analyte separation (see materials and methods section for column information and 
optimized conditions). 
 
Table 4.3 List of components in the standard mixture with their observed m/z and 
associated retention times 
 
Component 
 
Observed m/z 
(+ H+) 
Retention time 
(min) 
L-Cit  176 1.5 
H4B  242 2.1 
NOHA 191 5.2 
Na+ DTC 150 5.9 
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Figure 4.8 LC-MS chromatograms of standard reaction mixture off of PrimeSep Column 
directly interfaced to ESI source operating in positive ion mode. 
 
 Maintaining the same conditions used in the Griess Assay experiments, reactions 
were set up with an aerated solution of Ru(II)K115C-gsNOS in sodium phosphate buffer, 
pH 7 and loaded with substrate (NOHA). The H4B cofactor and the DTC quencher were 
added, and the mixture was irradiated with 470 nm light from an LED for 45 minutes. 
Following irradiation, the protein was removed using amicon micron centrifugal filter 
devices (10,000 MWCO) prior to LC–MS analysis. Formation of L-Cit was confirmed by 
both retention time and tandem mass fragmentation. A representative chromatogram and 
mass spectrum for the reaction are shown in Figure 4.9. 
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Figure 4.9 Confirmation of L-Cit production from the Ru(II)K115C-gsNOS photoreaction 
by 1.5 min retention time and m/z = 176 from standards. All the other components are 
present, but not shown for clarity. The new peak with a 4.9 min retention is unassigned, 
however, there are other possible species present in the reaction mixture such as the DTC 
dimer formed in the irreversible reductive quenching of the *Ru(II) excited state that were 
not accounted for in the standards. 
 
4.3 Conclusion 
 Experiments have been performed to test the efficacy of our photosensitizer-
labeled gsNOS enzyme, Ru(II)K115C-gsNOS, and excitingly, light-driven catalysis has 
been demonstrated under reductive flash-quench conditions. The Griess Assay was used 
to indirectly measure NO production via quantification of its NOx metabolites in aqueous 
solution. LC-MS was used to directly detect L-citrulline as the other photoreaction 
product and its formation was confirmed both by retention time and tandem mass spec 
fragmentation. Given that NO production (measured by the Griess Assay) starting from 
L-Arg is low compared to NOHA, but still increases with reaction time, it would be very 
informative to repeat those conditions and use LC–MS to see if any amount of L-Cit is in 
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fact produced. Control reactions that remove the [Ru(bpy)2(A-phen)]2+ complex, the 
substrate NOHA, or the light source show almost complete shut-down of catalysis. 
Controls that contain the [Ru(bpy)2(A-phen)]2+ complex (either attached to the protein or 
free in solution) and NOHA, but remove either the DTC quencher or the H4B cofactor 
still produce some amount of NOx upon illumination. It is possible that these NOx species 
are the result of *Ru(II) excited state quenching by oxygen to form ROS that can go on to 
do chemistry with the substrate. Two L-Arg analogs were investigated for their ability to 
inhibit NO production in the fully loaded Ru(II)K115C-gsNOS system; addition of either 
Me-L-Arg or NO2-L-Arg resulted in ~50% inhibition. Time-course reactions show 
maximum NO production of ~150 µM at 7 hours starting with 10 µM Ru(II)K115C-gsNOS 
and 200 µM NOHA. While it is likely that some amount of unavoidable photooxidative 
damage to the protein occurs over time, it may be possible to boost NO production by 
increasing the starting concentration of substrate.  
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4.5 Materials and Methods 
Materials 
Labeled protein Ru(II)K115C-gsNOS was prepared as described in chapter two of 
this thesis. The model complex [Ru(bpy)2(A-phen)]2+ was synthesized as described in 
chapter three. Note: all ruthenium(II) diimine-containing samples (model and protein) 
were kept covered in foil or handled under red light to prevent photodamage.  L-arginine 
(L-Arg), N!-hydroxy-L-arginine acetate salt (NOHA), (6R)-5,6,7,8-tetrahydrobiopterin 
(H4B), sodium diethyldithiocarbamate (DTC), N
!-methyl-L-arginine (Me-L-Arg), and 
N!-nitro-L-arginine (NO2-L-Arg) were all purchased from Sigma-Aldrich and used as 
received. NOHA, Me-L-Arg, and NO2-L-Arg were all stored at 4 °C and freshly dissolved 
before each use. H4B was stored at -20 °C. 50 mM sodium phosphate (NaPi) buffer, pH 7 
was prepared using Milli-Q (18.2 M") water and filtered (0.22 µm, Millipore) before 
use. The Nitrate/Nitrite Colorimetric Kit containing Greiss reagents, standards, and the 
nitrate reductase was purchased from Cayman Chemical Company. 
Griess Assay 
Griess Assays were performed according to the manufacturer’s instructions with 
the following changes. Absorbance was measured in a 1 cm pathlength microcuvette (200 
µL sample volume) instead of using the micro well plate supplied with the kit for use 
with an absorbance platereader. Due to the longer pathlength used in our experiments, 
nitrate/nitrite standard curves were made with more dilute solutions (0–15 µM) than 
outlined in the kit to keep absorbance < 1. 
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Typical experiments were set up in parallel, starting from freshly prepared stocks 
of each reaction component. Sample volumes were 80 µL and were made up in thin-
walled PCR tubes (which are fairly transparent to visible light). Steady-state illumination 
was achieved using a 470 nm light emitting diode (LED, M470L1, Thorlabs) operating at 
the LED driver maximum current (~700 mA). Following the desired photoreaction time, 
10 µL each of the nitrate reductase and cofactor mixture were added and incubated in the 
dark at room temperature for 1 hour. 50 µL Griess Reagent 1 was added, immediately 
followed by 50 µL Griess Reagent 2 bring the final volume to 200 µL. The color was 
allowed to develop for 10 min before recording absorbance. UV-visible absorption 
spectra were recorded on an Agilent 8453 UV-vis Spectrophotometer. Data were 
processed using Microsoft Excel (cringe). 
Liquid Chromatography-Tandem Mass Spectrometry 
The formation of L-citrulline was confirmed using on-line liquid chromatography-
mass spectrometery (LC–MS) and liquid chromatography tandem mass spectrometry 
(LC–MS–MS) in the Mass Spectrometry Facility at the California Institute of 
Technology.  The LC system consisted of an Accela 600 pump (Thermofisher, USA), an 
Accela Open CTC PAL Autosampler (CTC Analytics, Switzerland), and an external 
column heater (Supelco, USA). The LC columns were interfaced directly to an 
electrospray ionization (ESI) source (Thermofisher, USA) of an LTQ linear ion trap mass 
spectrometer, operated in the positive ion mode, and spectra were acquired from m/z 50 
to 300 over the length of the chromatographic run. In some experiments, tandem MS was 
utilized for full confirmation by retention time, mass, and fragment analysis.  
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DTC, NOHA, and L-Cit are all polar molecules and were thus expected to have 
very short retention times on the more typically used reversed phase LC columns. Three 
different columns were evaluated for their ability to separate trace amounts of L-Cit 
amongst much higher component concentrations: 1) Cogent Hydride column (MicroSolv, 
USA), 2.1 i.d. x 50 mm, 4.2  !m particle, 100 Å pore size, operated in normal phase 
separation mode, 2) Acquity UPLC BEH Amide column (Waters, USA), 2.1 i.d. x 150 
mm, 4.2 !m particle, 100 Å pore size, operated in hydrophobic interaction liquid 
chromatography (HILIC) separation mode, and 3) PrimeSep A column (SIELC 
Technologies, USA) 2.1 mm i.d. x 100 mm, 5 !m particle, 100 Å pore size, operated in 
mixed mode chromatography, reversed-phase ion-exchange separation mode. The 
PrimeSep A column (3) gave the most consistent separation and was the most tolerant of 
the high-salt reaction conditions (50 mM buffer). Optimized conditions were as follows:  
Mobile Phase A: 20 mM ammonium formate in 30% acetonitrile 
Mobile Phase B: 50 mM ammonium formate in 50% acetonitrile 
  Flow Rate: 200 µL/min  
Column Temperature: 40 °C 
Sample Injection Volume: 5 µL  
 
Analytes were eluted with the following gradient: 
Time 0.00 min 0%B 
Time 0.50 min 0%B 
Time 10.00 min 100%B 
Time 11.00 min 0%B 
Time 14.00 min 0%B 
 
Since the actual amount of L-Cit produced in the reaction would be much less than that in 
the standards, a low detection limit was explored.  A sample containing 60 pmoles of 
pure L-Cit was run and clearly detected under these conditions (Figure 4.10). 
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Figure 4.10 LC tandem MS of 60 pmoles L-Cit standard loaded onto PrimeSep A 
column, showing 1.5 min retention time and a detected m/z = 176. 
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DIATOMIC MOLECULE BINDING  
IN RUTHENIUM-MODIFIED NITRIC OXIDE SYNTHASE  
FROM GEOBACILLUS STEAROTHERMOPHILUS 
 
 
 
 
 
 
 
 
 
 
 
 
 
! "#$!
5.1 Introduction 
The radical nitric oxide (NO), is now recognized as an essential biological 
regulator after having been long considered solely a poison and pollutant.1 NO has many 
roles, such as an endothelian relaxing factor, a protective immunocytotoxin, and as a 
signaling molecule in the nervous system.2 NO is produced in mammals by a family of 
nitric oxide synthases (mNOS). mNOS catalyzes the oxidation of L-arginine (L-Arg) to 
L-citrulline (L-Cit) + NO. The reaction proceeds in two turnovers with N!-hydroxy-L-
arginine (NOHA) as a stable bound intermediate.3 All mNOS isoforms are homodimers 
that contain an oxygenase domain linked to a reductase domain.4 The oxygenase domain 
houses a cysteine-ligated heme, as well as substrate and redox cofactor binding sites that 
form the catalytic active site of the enzyme. The calmodulin-linked reductase domain is a 
source of electrons and has binding sites for flavin adenine dinucleotide (FAD), flavin 
mononucleotide (FMN), and nicotinamide adenine dinucleotide phosphate (NADPH).3 
Chapter one contains a more detailed description of the domains of mNOS enzymes. 
Monooxygenases, including chloroperoxidase (CPO), cytochromes P450, and 
NOS, belong to the heme-thiolate superfamily of enzymes that activate dioxygen (O2) to 
oxegenate substrates.5 While the full two-step mechanism of NO production by NOS is 
not yet fully understood,6 the first turnover is thought to follow a cycle similar to the 
well-studied P450s. The NOS resting state is a six-coordinate mixed-spin ferric-aquo 
heme. Substrate binding in the pocket displaces water to form a five-coordinate high-spin 
ferric state. In the first turnover, L-Arg is converted to NOHA. Ferric NOS is supplied 
with an electron from the reductase domain to give a ferrous species that can bind O2. 
Oxygen binding gives a ferrous-oxy complex, that is further reduced by one electron 
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coming from the unique redox cofactor (6R)-5,6,7,8-tetrahydrobiopterin (H4B).7 To date, 
the next experimentally observed species is the ferric resting state with bound NOHA. 
The second turnover of the catalytic cycle has similar steps: reduction, O2-binding, and 
reduction by H4B. From there, the next observed species is the ferric-NO, which then 
releases NO. The missing reactive intermediates involved in these heme-based 
oxygenations are thought to be a ferryl porphyrin radical cation (analogous to compound 
I in P450) in the first turnover and either a hydroperoxo ferriheme or Cpd I formed by 
subsequent protonation/water loss in the second8,9 (Figure 5.1).  
 
Figure 5.1 Putative mechanism for the catalytic production of NO by NOS enzymes: (1) 
first turnover formation of NOHA from L-Arg, shown in blue path; (2) second turnover 
formation of L-Cit and NO radical from NOHA, shown in orange path. The proposed 
oxygenating intermediates are in brackets. 
 
Many bacterial NOS homologs have been identified that exhibit NOS-like 
activity.10 The role of NO in prokaryotes remains an open question, but in vivo NO 
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production has been confirmed.11 A key difference between bacterial NOS and mNOS is 
the absence of a linked reductase domain. Three bacterial forms of NOS have been 
crystallized from Bacillus subtilis (bsNOS),12 Staphylococcus aureus (saNOS),13 and 
Geobacillus stearothermophilus (gsNOS).14 All form stable dimers. Their structures are 
very similar to each other and to the oxygenase domain of mNOS (Figure 5.2), but 
bacterial NOS lack part of the H4B binding domain.2 Despite slight differences in heme 
electronics and substrate/cofactor binding, bacterial NOS and mNOS are suggesed to 
share the same mechanism for catalytic production of NO from L-Arg via the bound 
NOHA intermediate.15 There are various advantages to working with bacterial NOS 
including good expression yields in E. coli and increased stability.16 Lessons learned 
from these NOS-like enzymes can be applied to their mammalian counterparts.  
 
Figure 5.2 Comparison of representative dimeric structures of bacterial and mammalian 
NOS showing nearly identical overall folds: a) Bacillus subtilis, highlighting alternate 
bound cofactor, tetrahydrofolate (THF); b) inducible NOS from mammalian 
macrophages, highlighting bound cofactor, tetrahydrobiopterin (H4B) and the missing N-
terminal hook in pink (reproduced from Pant12).  
 
 It is of great interest to understand how NOS interacts with diatomic ligands since 
O2 is a reactant (cosubstrate) and NO is a product in this very complex transformation. 
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Various techniques, including UV-visible spectroscopy,15 stopped-flow 
spectrophotometry,17 X-ray crystallography,18,19 Electron Paramagnetic Resonance 
(EPR)/Electron-Nuclear Double Resonance (ENDOR),8 and Raman spectroscopies,20,21 
have been used to gain insight into interactions of diatomics with mNOS and bacterial 
NOS. Studies involving O2 are challenging, so both NO and carbon monoxide (CO) have 
been used as surrogates for gas-binding. Single-turnover experiments are better suited for 
studies of NO release.22,23,24,25  
There are many open questions about gas diffusion pathways and interactions of 
diatomics with heme while substrate/cofactor are bound. Despite lacking part of the H4B 
binding site, bacterial NOS binds H4B at the dimer interface with residues from each 
subunit.2 Crystal structures of bsNOS show formation of a destabilized “loose” dimer that 
converts to a “tight” dimer upon substrate/cofactor binding in a cooperative fashion.26 
Another significant difference between mammalian and bacterial NOSs is in the notably 
slower NO-release rates observed for bacterial NOS enzymes.2 Structure and sequence 
comparisons reveal variations in a few key residues thought to “gate” NO release.12,25 For 
example, a conserved Val located directly above the distal side of the heme in mNOS is 
substituted by an Ile in many bacterial NOSs; this substitution is thought to slow gas 
release by sterically constraining the active site.27 The second gate residue shows more 
variation, both in position and size of residue, but again NO-release rates seem correlated 
with steric bulk.14,25 These gate effects on NO-release have been studied by single-
turnover experiments. Taken together, substrate/cofactor binding, as well as amino acid 
composition along diffusion pathways, create structural and electronic changes that affect 
the interaction of gsNOS with diatomics. 
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NOS from the thermostable and nonpathogenic bacterium, Geobacillus 
stearothermophilus (gsNOS), presents a unique and convenient system to study. The 
three-dimensional structure of gsNOS is remarkably similar to other bacterial NOS 
enzymes, as well as mNOSoxy.14 However, gsNOS has more constrained distal and 
proximal heme environments, a slightly more compact overall fold as compared with 
other bacterial NOS, and exhibits the slowest recorded NO-release rate of all NOS 
enzymes studied to date.14  
Given these interesting properties, it is of interest to study the process by which 
diatomic molecules bind to gsNOS, in addition to diatomic release. CO binds to ferrous 
heme and thus can be used as a surrogate for O2 binding, as mentioned above. Flash 
photolysis of preformed ferrous-CO adducts is a useful technique for studying 
interactions of heme proteins with diatomics.28–30 Excitation by visible light causes rapid 
CO dissociation and because the iron retains its Fe(II) oxidation state, the released CO 
can rebind. This rebinding process can be followed by transient absorption (TA) 
spectroscopy that monitors changes in the heme Soret maxima (e.g., ferrous NOS-CO 
!max = 446 nm vs. ferrou NOS !max = 415 nm).19 Preliminary CO-photolysis experiments 
have been performed previously with gsNOS variants to determine whether diatomic 
ligand rebinding (in addition to NO release) is affected by channel gating.31 While these 
types of experiments are extremely useful, they do not necessarily report on the direct 
binding event. Furthermore, these initial studies were performed in the absence of 
substrate, which has substantial effects on the heme active site and overall gsNOS 
dimeric structure.  
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A method of triggering rapid heme reduction (faster than mixing) is needed to 
study the direct binding event of diatomic molecules such as O2 or CO to gsNOS. The 
Gray group has developed “flash-quench” methodology32 to trigger redox events in small 
molecule33,34 and protein35 systems and is described in detail in chapters one and three of 
this thesis. Briefly, laser excitation (the “flash”) into the metal-ligand charge-transfer 
(MLCT) band of a ruthenium(II)diimine photosensitizer creates an electronic excited 
state. Introduction of another small-molecule in solution (the “quench”) can lead to the 
formation of either a potent -1.3 V reductant, [Ru(bpy)3]1+, or +1.3 V oxidant, 
[Ru(bpy)3]3+.36 From there, electrons can either be injected into or pulled from the heme, 
in the case of NOS.  
Previous chapters of this thesis describe covalent attachment of a [Ru(bpy)2(IA-
phen)]2+ photosensitizer (where IA-phen = 5-iodoacetamido-1,10-phenanthroline) to an 
engineered Cys115 on the surface of gsNOS, forming the Ru(II)K115C-gsNOS conjugate. 
Under reductive “flash-quench” conditions, this modification provides a route to bypass 
the need for a separate reductase domain and allows for phototriggered heme reduction. 
Chapter three describes initial laser studies showing formation of the ferrous species with 
a rate of kobs = 1.6 x 106 s-1 (! = 625 ns) that is independent of presence of L-Arg or 
NOHA substrate or H4B cofactor. In the hopes of observing downstream intermediates in 
the NOS catalytic cycle, experiments were performed in the presence of oxygen. 
Unfortunately the kinetics were extremely complicated by the redox-active nature of O2, 
presumably due to interactions with the transiently formed Ru(I) label and/or the 
reductive quencher. Thus, while we were able to generate the ferrous heme, we were 
unable to definitively assign formation of a ferrous-oxy species. In order to explore the 
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diatomic binding event, we turn to CO as a redox-inactive substitute. Using similar 
reductive flash-quench conditions with our Ru(II)K115C-gsNOS conjugate, we hope to 
initiate direct CO-binding as shown in Scheme 5.1. Given the large changes in heme 
absorbance upon formation of Fe(II)-CO, transient absorption (TA) spectroscopy can be 
used to observe this binding reaction. Furthermore, experiments in the presence of 
substrates can be performed to investigate their effects on diatomic ligand interactions 
with the active site of gsNOS. 
 
Scheme 5.1 Reductive flash-quench scheme for CO-binding upon heme reduction in 
gsNOS. Ru represents the [Ru(bpy)2(IA-phen)]2+ complex attached to gsNOS, Q 
represents the quencher p-methoxy-N.N-dimethylanaline (MeODMA), and Fe represents 
gsNOS heme. 
 
5.2 Results and Discussion  
Reductively Quenching the Model Complex [Ru(bpy)2(A-phen)]2+in the Presence of CO 
Photophysical properties of the model complex [Ru(bpy)2(A-phen)]2+ (where A-
phen = 5-acetamido-1,10-phenanthroline) were explored under an atmosphere of CO. 
These experiments were performed in order to determine whether the presence of CO 
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would affect formation rates of the *Ru(II) excited state or the reductive quenching by p-
methoxy-N.N-dimethylanaline (MeODMA) to form the Ru(I) state. As described in 
chapter three, the *Ru(II) excited state is luminescent with an emission maximum 
centered around 630 nm. Following 480 nm laser excitation into the tail of the Ru(II) 
MLCT band, the *Ru(II) luminescence decays with a lifetime on the order of ! ~1 µs. 
Upon introduction of excess MeODMA, the luminescence decay at 630 nm is effectively 
quenched with a pseudo-first-order rate constant of k = 1.7 x 107 s-1 (! ~ 60 ns), providing 
a rate of Ru(I) formation. These experiments were repeated under an atmosphere of CO 
and no changes to the quenched lifetime were observed.  
TA was measured for the same samples at wavelengths in the region of both 
Ru(II) absorbance and the heme Soret (400–440 nm). In the presence of MeODMA 
quencher, TA traces of the [Ru(bpy)2(A-phen)]2+ model complex exhibit a nearly 
instantaneous initial bleach (negative optical density, !OD < 0) indicative of *Ru(II) 
excited state formation, followed by a return to baseline suggesting formation of the 
Ru(I) species with a rate constant similar to that of the luminescence decay. These rates 
are unchanged in the presence of CO (Figure 5.3). As discussed in Chapter Three, there is 
a further increase in !OD that develops at longer timescales (~100 µs) that is tentatively 
assigned to side reactions of the MeODMA radical cation over time. These data indicate 
that CO does not interact with the model complex or the quencher to affect formation of 
transient species in the flash-quench scheme. 
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Figure 5.3 Representative transient absorption at 440 nm for the quenched model 
complex [Ru(bpy)2(A-phen)]2+ in the presence and absence of CO showing initial bleach 
from *Ru(II), the formation of Ru(I), and slight positive !OD at longer timescales. 
[Ru(bpy)2(A-phen)]2+] = 8 µM and [MeODMA] = 8 mM, 50 mM sodium phosphate 
buffer, pH 7. 
 
Phototriggered CO-binding of Ru(II)K115C-gsNOS  
 Luminescence decay (630 nm) for the *Ru(II) excited state of our photosensitizer-
labeled gsNOS system, Ru(II)K115C-gsNOS, is described by a biexponential function (!1 = 
1.2 µs and !2 = 150 ns). These rates likely reflect multiple solution conformations of the 
label that do not interconvert within the timescale of these measurements. The same rates 
and distribution are observed in the presence of CO, indicating that CO does not interact 
with the *Ru(II) excited state. Addition of excess MeODMA quencher results in a faster 
luminescence decay with a single observed lifetime (!quenched = 60 ns), similar to that of 
the quenched model complex. Experiments performed in the presence of CO yield the 
! "#$!
same quenched rate (!quenched,CO = 63 ns), again suggesting that the rate of Ru(I) formation 
is unaffected by CO. Figure 5.4 shows luminescence data for the Ru(II)K115C-gsNOS 
system under the above experimental conditions. The *Ru(II) excited state is the only 
emissive species in our system, so transient luminescence data alone do not report on 
what is happening at the heme center of gsNOS. 
 
Figure 5.4 Luminescence decays for the labeled protein Ru(II)K115C-gsNOS showing 
unquenched and quenched lifetimes are unaffected by CO. Samples were excited at 480 
nm and monitored at 630 nm. [Ru(II)K115C-gsNOS] = 8 µM and [MeODMA] = 8 mM, 50 
mM sodium phosphate buffer, pH 7. 
 
 As mentioned above, there are changes in the gsNOS Soret maximum upon 
reduction and CO-binding. Chemically reduced samples were prepared in a glove box 
and back-filled with CO to obtain ground state UV-visible spectra of the species we hope 
to generate transiently under flash-quench conditions (Figure 5.5). The resulting 
difference spectrum provides a spectroscopic handle for TA measurements. 
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Figure 5.5 UV-visible absorption spectra of Ru(II)K115C-gsNOS showing Soret maxima 
for the Fe(III) heme, chemically reduced Fe(II), and Fe(II)-CO species. Inset: difference 
spectrum between the oxidized resting state and chemically prepared Fe(II)-CO 
Ru(II)K115C-gsNOS.  
 
TA measurements were performed to track changes in both the ruthenium 
photosensitizer and at the gsNOS heme active site for our Ru(II)K115C-gsNOS system. In 
the absence of quencher we have previously observed laser-induced formation of the 
*Ru(II)K115C-gsNOS-Fe(III) excited state that is characterized by a negative !OD in the 
Ru(II) absorbance (400–440 nm) with a return to baseline on the same timescale as its 
luminescence decay. We found no evidence for transient species associated with changes 
in the heme Soret absorbance. These same measurements made in the presence of CO 
show slight qualitative differences in their returns to baseline (to the Ru(II) ground state) 
(Figure 5.6). However, fitting the data to biexpoential functions yields essentially the 
same lifetimes (!1 = 1.0 µs and !2 = 140 ns; !1,CO = 1.3 µs and !2,CO = 130 ns), similar to 
the rates observed for the luminescence decays.  
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Figure 5.6 Transient absorption data at 440 nm of unquenched Ru(II)K115C-gsNOS in the 
presence and absence of CO. Inset: data from early timescale, fit to biexponential 
functions. [Ru(II)K115C-gsNOS] = 8 µM, 50 mM sodium phosphate buffer, pH 7. 
 
 We know from previous experiments (detailed in chapter three) that ferrous 
gsNOS forms under reductive flash-quench conditions. If CO binds, we expect to see a 
further red shifted heme Soret at 440 nm (Figure 5.5). The next step was to measure TA 
in the presence of MeODMA quencher and CO. TA traces at 440 nm for quenched 
Ru(II)K115C-gsNOS in the presence and absence of CO both show the expected faster loss 
of *Ru(II) signal and an overall increase in !OD at intermediate times associated with the 
formation of ferrous heme. However, the samples containing CO show less intensity 
associated with Fe(II) formation, followed by a large increase in !OD at longer times 
(Figure 5.7). We assign this new transient species as Fe(II)-CO. Despite the differences in 
early signal intensity, the biexponential fits show similar rates with time constants !1,CO = 
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70 ns and !2,CO = 770 ns (as compared with samples under argon, !1 = 62 ns and !2 = 625 
ns). The bimolecular rate of Fe(II)-CO formation cannot be extracted without kinetics 
modeling of CO concentration dependence studies, which have not yet been conducted. 
However the observed signal forms on the order of ~1 ms and is consistent with rates 
observed in CO-photolysis studies where the rebinding process is monitored.31 The final 
decay back to baseline is assumed to be associated with reoxidation by the MeODMA 
radical cation, a process that would release CO from the heme. 
 
Figure 5.7 Transient absorption data at 440 nm of quenched Ru(II)K115C-gsNOS in the 
presence and absence of CO. Inset: data from early timescale, fit to biexponential 
functions. [Ru(II)K115C-gsNOS] = 8 µM, [MeODMA] = 8 mM, 50 mM sodium phosphate 
buffer, pH 7. 
 
The assignment of Fe(II)-CO was confirmed by TA measurements at multiple 
wavelengths. These data show bleached signals measured at 400 and 420 nm at rates 
concomitant with the increase in !OD at 440 nm (Figure 5.8). 
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Figure 5.8 Transient absorption data at multiple wavelengths of quenched Ru(II)K115C-
gsNOS + CO. [Ru(II)K115C-gsNOS] = 8 µM, [MeODMA] = 8 mM, 50 mM sodium 
phosphate buffer, pH 7. 
 
Removal of CO from the sample by equilibrating overnight under argon basically 
results in a return to the signals seen in samples that were never exposed to CO. There is 
still slightly increased !OD at longer timescales, that may come from small amounts of 
Fe(II)-CO formed due to residual CO in the protein matrix during degassing. 
Alternatively, it could be the result of more thorough degassing in general that extends 
the natural lifetime of the ferrous species. Interestingly, the signals coming from initial 
formation of Fe(II) reach the same intensity, indicating that the lower intensity seen in 
CO samples comes from CO-binding and not from some other differences in the 
Ru(II)K115C-gsNOS sample (Figure 5.9). 
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Figure 5.9 Transient absorption data at 440 nm of quenched Ru(II)K115C-gsNOS 
comparing samples made in the absence of CO, presence of CO, and then degassed with 
Argon to remove CO. [Ru(II)K115C-gsNOS] = 8 µM, [MeODMA] = 8 mM, 50 mM 
sodium phosphate buffer, pH 7. 
 
 
Phototriggered CO-binding of Ru(II)K115C-gsNOS in the Presence of Substrates 
The same flash-quench experiments described in the previous section with 
Ru(II)K115C-gsNOS in the presence of CO were performed with substrate bound. As 
before, CO-binding was monitored by TA and assigned by large positive !OD signals at 
440 nm. The experiments with L-Arg bound show very little CO binding. Samples with 
NOHA bound show markedly increased Fe(II)-CO formation compared with L-Arg, but 
still less than substrate-free enzyme (Figure 5.10). Differences between the two substrates 
can be rationalized by their different modes of interaction with diatomic ligands in the 
active site of gsNOS as previously reported.21 
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Figure 5.10 Transient absorption data at 440 nm of quenched Ru(II)K115C-gsNOS + CO 
in the presence of each substrate. [Ru(II)K115C-gsNOS] = 8 µM, [MeODMA] = 8 mM, [L-
Arg] = [NOHA] = 200 µM, 50 mM sodium phosphate buffer, pH 7. 
 
These data that show less overall CO binding were initially confusing given that 
L-Arg or NOHA must be bound in the active site before the O2 binding events in the 
native NOS cycle. There are differences between the binding modes of O2 and CO: O2 
adopts a bent geometry and CO binds linearly to Fe(II) heme. But it still seems unlikely 
that substrate binding would sterically exclude a diatomic molecule of comparable size. 
This difference in binding can be explained however, if one considers the large overall 
structural and active site changes associated with substrate binding seen in bacterial NOS 
enzymes. As previously mentioned, crystal structures of NOS from Bacillus subtilis 
(bsNOS) show two distinct dimer conformations in the presence and absence of 
substrate/cofactor: a “tight” and “loose” form (Figure 5.11).26 Substrate/cofactor binding 
induces formation of the “tight” dimer, resulting in structural changes at the interface that 
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bring the two heme active sites closer by approximately 3 Å and translates the subunits 
by 11 Å. The buried surface area at the dimer interface condenses from 1115 to 480 Å2 
per subunit. Furthermore, the helical T-regions lose most of their interactions in the 
“loose” form, whereas they make close contacts in the “tight” form that are crucial to 
dimer stability. The consequence of this increased peripheral rigidity and increased dimer 
association is that the heme is markedly less solvent-exposed in the presence of 
substrate/cofactor. Furthermore, H4B binding blocks the proximal channel. 
 
Figure 5.11 Ribbon diagrams of the crystal structures of bsNOS in presence and absence 
of substrate/cofactor. Subunits are shown in pink and light blue. a) bsNOS with the bound 
substrate L-Arg forms a “tight” dimer with close contacts formed by the helical T and N-
terminal hairpin from each subunit and b) bsNOS in the absence of substrate forms a 
“loose” dimer and translates one subunit by approximately 11 Å exposing 50% more 
surface area. Figure reproduced from Pant.26 
 
If such a dimeric contraction is occurring with our Ru(II)K115C-gsNOS system, it 
could account for the decreased amount of Fe(II)-CO formation in the presence of 
substrate. To investigate whether more time was needed to allow CO access to the 
interior of the contracted substrate-bound protein, two experiments were performed. One 
where L-Arg-bound gsNOS was chemically reduced in an anaerobic chamber and then 
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back-filled with CO and another where the samples containing L-Arg were allowed to 
pre-equilibrate overnight under an atmosphere of CO before flash-quench. Given the 
steady-state nature of the first experiment, collection of UV-visible absorption spectra 
were enough to definitively show that reduced L-Arg-bound Ru(II)K115C-gsNOS is 
capable of binding CO (Figure 5.12). Opening the cuvette to air results in the reoxidation 
to the Fe(III) state over minutes and the release of CO. 
 
Figure 5.12 UV-visible absorption spectra of Ru(II)K115C-gsNOS showing Soret maxima 
for chemically reduced Fe(II) and Fe(II)-CO species both bound to L-Arg. The broader 
Soret in the original Fe(III) spectrum is due to lack of substrate in that sample. 
 
TA measurements of the pre-equilibrated sample in the second experiment were 
performed and show more formation of the L-Arg-bound Fe(II)-CO species as compared 
to freshly made L-Arg samples. This adds further support to the idea that more time is 
required for CO to access the heme in the contracted dimer (Figure 5.13). 
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Figure 5.13 Transient absorption data at 440 nm of quenched L-Arg-bound Ru(II)K115C-
gsNOS given time to equilibrate with CO overnight. [Ru(II)K115C-gsNOS] = 8 µM, 
[MeODMA] = 8 mM, [L-Arg] = 200 µM, 50 mM sodium phosphate buffer, pH 7. 
 
It is very likely that substrate binding has profound effects on both diatomic gas 
binding and release. Raman studies of CO-bound gsNOS in particular show unique 
environments in both the distal and proximal heme cavities upon diatomic binding in the 
absence of substrate/cofactor suggesting two distinct populations of ferrous-CO are 
present.21 Indeed, flash-photolysis studies of CO re-binding of substrate-free gsNOS 
show biexponential behavior suggesting two different binding modes.31 This is different 
than the single NO-release rate observed in single-turnover experiments loaded with 
substrate and cofactor.25  
Furthermore, two NO-release “gate” residues have been identified in NOS.12,25 
Bacterial NOS enzymes have a bulkier Ile at position 223, directly above the heme in the 
distal pocket, and a His at position 134 in the substrate channel. Swap mutations have 
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been prepared in bsNOS and lead to increased NO-release rates.27 These “gate” mutations 
have been made in gsNOS (Ile223Val, His134Ser, and Ile223Val/His134Ser)25 to explore 
the pathway for diatomic release. The resultant rates of NO-release were measured and it 
was observed that less bulk at these positions resulted in faster NO release rates, 
supporting the idea that bulk gates the release of NO. Flash-photolysis studies of CO re-
binding of these substrate-free gsNOS “gate” mutants were complicated by biexponential 
behavior. It would be greatly informative to perform the flash-quench direct CO-binding 
studies described in this chapter on these mutants in the presence of substrate, as well as 
cofactor. This type of measurement could then be compared to the NO-release single-
turnover experiments to investigate whether diatomic binding and release share the same 
pathway. Additional mutations could be made to increase the bulk in the distal channel. 
Inspection of space-filling models of gsNOS in Pymol suggest that the single mutants 
Ile223Leu, His134Trp, and the double mutant Ile223Leu/His134Trp would provide more 
channel bulk, without fully blocking substrate access. If CO-binding rates remain the 
same, while NO-release is slowed, that would provide information that diatomic binding 
occurs through a different pathway than release. 
 
5.3 Conclusion 
It is of interest to understand how NOS interacts with diatomic ligands since O2 is 
a reactant (cosubstrate) and NO is a product in the catalytic cycle. CO can be used as a 
redox-inactive surrogate for O2, as it also binds to ferrous heme. Fe(II)-CO produces a 
large shift in the Soret absorbance that can be used as a spectroscopic handle in transient 
absorption measurements. Reductive flash-quench experiments have been performed 
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using our Ru(II)K115C-gsNOS system to transiently reduce the heme and allow CO 
binding. TA measurements show clear formation of the Fe(II)-CO adduct on the order of 
1 ms, however further experiments are needed to extract the bimolecular rate constant. 
Measurements made with substrate-bound Ru(II)K115C-gsNOS show differing amounts of 
Fe(II)-CO formation. These data suggest that the observed substrate-induced structural 
changes in both the dimer and the active site itself could play a role in diatomic gas 
binding. This is the first study where the direct binding event of CO to NOS has been 
observed and represents a starting point for deeper investigations into the factors that 
affect diatomic ligand binding in NOS. 
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5.5 Materials and Methods 
Labeled protein Ru(II)K115C-gsNOS was prepared as described in chapter two of 
this thesis. L-arginine (L-Arg, Sigma) was used as received and stored at room 
temperature. N!-hydroxy-L-arginine acetate salt (NOHA, Sigma) was stored at 4 °C and 
freshly dissolved before each use to prevent hydrolysis. (6R)-5,6,7,8-tetrahydrobiopterin 
(H4B, Sigma) was stored at -20 °C. The model complex [Ru(bpy)2(A-phen)]2+ and  p-
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methoxy-N.N-dimethylanaline (MeODMA) were prepared and handled as described in 
chapter three.  
General Sample Preparation 
All samples were prepared in 50 mM sodium phosphate (NaPi) buffer, pH 7 using 
Milli-Q (18.2 M!) water and filtered (0.22 µm, Millipore) before use. Note: all 
ruthenium(II) diimine-containing samples were kept covered in foil or handled under red 
light to prevent photodamage. Specialized 1 cm pathlength quartz cuvettes (Starna Cells) 
fitted with Kontes valves and side-arm ground-glass Schlenk adaptors were made in-
house at the Caltech glassblowing shop (Rick Gerhart). Cuvettes containing micro stir 
bars were attached to a Schlenk line and degassed by three sets of ten pump-purge cycles 
(very quick vacuum, followed by argon back-filling) spaced in 15 min intervals. This 
method provides a gentle way to degas protein samples that avoids denaturation caused 
by bubbling. Argon gas was precleaned by a commercially available oxygen scrubber 
before entering the line (Oxiclear, Labclear).  
Samples for steady-state CO-binding were prepared in an anaerobic chamber 
(“wet” glove box used for aqueous samples) under an inert atmosphere of nitrogen. 
Ru(II)K115C-gsNOS was reduced with sodium dithionite. Excess dithionite was removed 
using a PD-10 desalting column (GE Healthcare), equilibrated with degassed NaPi 
buffer, pH 7. L-Arg was added to the samples, which were then sealed in quartz cuvettes 
fitted with a Kontes valve and a side-arm ground-glass Schlenk adaptor (as previously 
described for degassed samples). The sealed samples were removed from the box and 
attached to a separate Schlenk line containing carbon monoxide. The cuvettes were back-
filled with CO following the pump-purge method described for argon to provide a nearly 
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100% CO atmosphere in the cuvette. Given the toxicity of CO, extra care was taken when 
using this line, including the use of a CO monitor in the hood. 
Typical sample volumes for TA measurements were 2 mL to provide enough 
height in the cuvette to accommodate both a micro stir bar and the width of laser/probe 
light without spatial interference. Labeled protein and model complex concentrations 
were chosen to balance decent signal size with ground state absorbance in the range of 
0.8 OD at the Soret maximum and 0.4 at the Ru shoulder. Quencher concentrations were 
kept at 1000-fold excess to allow fitting of pseudo-first-order kinetics. Substrate 
concentrations were chosen to ensure all proteins were bound and mimicked conditions 
used in published single-turnover studies. Sample component concentrations were as 
follows: [Ru(II)K115C-gsNOS] = 8 µM, [[Ru(bpy)2(A-phen)]2+] = 8 µM, [MeODMA] = 8 
mM, [L-Arg] = 200 µM, and [NOHA] = 200 µM. 
Spectroscopic Measurements 
All steady state and time-resolved spectroscopic measurements were carried out at 
the Beckman Institute Laser Resource Center. UV-visible absorption spectra were 
recorded on an Agilent 8453 UV-vis Spectrophotometer. Laser excitation for time-
resolved measurements was provided by 8 ns pulses from a 10 Hz Q-switched Nd:YAG 
laser (Spectra-Physics Quanta-Ray PRO-Series). The third harmonic (355 nm) was used 
to pump an optical parametric oscillator (OPO, Spectra-Physics Quanta- Ray MOPO-700, 
tunable in the visible region). Laser light from the OPO at 480 nm with a final power of 
approximately 10 mJ/pulse (at the sample) was used to excite samples. Probe light for 
transient absorption kinetics measurements was provided by a 75 W arc lamp (PTI Model 
A 1010). Details and schematics for the laser and optical configuration for transient 
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luminescence and absorption measurements can be found in the methods section of 
chapter three. 
Data Fitting 
 Initial transient absorption data manipulation was performed using MATLAB 
R2010a (Mathworks, Inc.) as follows: for each wavelength, data from three different 
timescales (2 µs, 100 µs, and 100 ms) were logarithmically compressed with 600 points 
per decade. The compressed data were adjusted to match intensities by inspection, spliced 
together, and the x-axis was shifted to set the signal rise to t = 0. Data were fit to multiple 
exponentials using nonlinear least-squares minimization and quality of fit was evaluated 
by inspection of residuals. Global least-squares analysis was used to fit data from 
multiple wavelengths to a single set of rates and amplitudes. Simple biexponential fitting 
for TA data and all TA plots were made using IgorPro 6.1 (Wavemetrics). UV-vis data 
were processed using Microsoft Excel. 
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